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FOREWORD
Beri-beri has been known for centuries; its relation¬
ship to a vitamin deficiency state, subsequently identified
as thiamine, has been appreciated since 1885. Although the
incidence of beri-beri has greatly decreased, significant
numbers of people still develop thiamine depletion syndromes.
Thiamine deficiency is a major cause for clinical abnormal¬
ities in the malnourished alcoholic (Baker et al., 1964; Leevy
et_al., 1965a; Leevy et al, 1965b; Fennelly et al♦, 1964;
Fennelly et al., 1967; Thomson, Baker and Leevy, 1968; Leevy
h<*o ■ ' ' ;
and Baker, 1968 and Leevy, Thomson and Baker, 1969) and is
frequently present in elderly subjects (Brin et al., 1964;
Brin et al., 1965; Griffiths et al., 1965). Knowledge of the
site and mechanism of thiamine absorption in animals is still
incomplete despite numerous experimental studies and no
satisfactory routine test has been developed to measure
absorption in man.
It was the purpose of this work to develop a test to
measure absorption in man using 35S-thiamine hydrochloride.
This provided a method to investigate the route and mechan¬
ism of thiamine hydrochloride absorption in man and to study
factors which modify it. Special attention was directed to
the influence of gastrointestinal disease, age, hepatic
steatonecrosis and renal disease. The site of the
xvi
absorption defect found in the alcoholic patient was studied
and the aetiological roles of ethanol administration and
malnutrition were investigated. The utilization of a dif¬
ferent mechanism and greater absorption in man incident to
changes in the molecular configuration of thiamine (to
produce the analogue thiamine propyl disulphide, TPD) were
studied and its use in the treatment of thiamine deficiency
syndromes was evaluated.
The investigations were begun in the Department of
Therapeutics, University of Edinburgh, where I was working
under the close supervision of Dr. I. W. Delamore and Pro¬
fessor R. H. Girdwood who first introduced me to the problem
of thiamine absorption and guided and encouraged me during
the difficult early stages of the investigation. A leave of
absence was granted to allow me to continue my work in the
Department of Hepatic Metabolism and Nutrition, New Jersey
College of Medicine. During this time I was working under
the direction of Professor Herman Baker and the head of the
department, Professor Carroll M. Leevy. I would like to
express my deep gratitude for their invaluable guidance and
sincere interest during my graduate training.
I should also like to thank Professor T. Hastings Wilson,
Department of Physiology, Harvard Medical School, Professor
R. B. Fisher; Dr. G. Boyd of the Department of Biochemistry,
and Professor L. G. Whitby, Department of Clinical Chemistry,
xvii
University of Edinburgh for their encouragement, interest
and criticisms.
Financial support during this period was provided by
a University of Edinburgh Research Scholarship, Richard
Brown Scholarship, British Medical Association Scholarship
and Walter Dixon Memorial Scholarship and a Research
Fellowship from the National Institutes of Health.
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CENERAL INTRODUCTION
Principles of absorption tests in human subjects
Methods for the study of intestinal absorption were
reviewed by Verzar ana McDougall in 1936. Since then raany
new techniques have been developed (Levin, 1967). Different
approaches have evolved because no single method or parameter
is satisfactory for characterizing intestinal absorption and
many induce changes which influence the interpretation of the
data.
Absorption of a substance by the mucosal c"»ll refers to
movement of that substance from the intestinal lumen into the
cell and movement from the cell into the subcellular tissue
space, blood and lymphatics (Parsons, 1970). This definition
implies movement in a particular direction and allows the
distinction to be made between influx from the lumen into the
mucosal cell and efflux from the cell. It should be recog¬
nized that absorption is the net result of two unequal fluxes
into and out of the cell at the luminal surface and two
similar fluxes occurring across the base of the cell.
The inaccessibility of the gastro-intestinal tract has
led to the development of invit.ro techniques to study intes¬
tinal absorption. Unfortunately, however, while providing
much valuable information the conditions are very different
from those prevailing in the intact animal and the results
xix
require confirmation by invivo experiments. Problems in
technique and experimental design meet their greatest diffi¬
culty in man. The methods reviewed will be divided into
those which assess absorption indirectly by measuring the
level of the substance in the blood or excretory products
and those which assess it directly in the intestine.
Indirect Methods.
Balance studies The classical method estimates absorption by
subtracting the total output of the substance over a period
from the total intake. The result of the balance depends upon
the combined action of absorption and excretion and cannot be
used for substances altered in the large bowel by bacteria.
The performance of the test may be difficult because of
problems in diet analysis and patient cooperation in regulation
of intake and accurate collection of specimens. Also, balance
studies give no information on the relative importance of
intestinal mobility, alterations in the chemical form of the
substance presented to the mucosa and the transfer across the
intestine.
Techniques based on rc?covery from the urine of the absorbed
substance or derivatives
McCance and Madders in 1930 introduced a method for
measuring the absorption in man of substances which are slowly
destroyed in the tissues but readily excreted in the urine.
Quantitative data was obtained from the rates of excretion of
xx
the substance in the urine when given orally with that
occurring after intravenous injection. From the results
obtained, R, the ratio of the sugar utilized per unit of
sugar excreted, was obtained. The sugar absorbed during any
period was given by
A= E(R+l)
Where E= sugar excreted during the same time.
Using this method, the authors were able to compare the rates
of absorption of xylose, arabinose and rhamose.
Tolerance tests. In 1865, Bence Jones investigated the rapid¬
ity of absorption of metals by measuring the presence of lithium
in the body fluids and tissues after administration of lithium
salts by mouth. Measurements of the test substance in blood
or urine following a single oral dose has been taken as an
index of the rate of absorption and a guide to the amount
absorbed. Such tests have been used for measuring the absorp¬
tion of substances like glucose, xylose, iron and fat in human
subjects (Duthia, 1967). Criticisms of the method were
reviewed by Josephs (1958). The principal drawbacks are (1)
the results are a combination of effects of absorption and
intermedary metabolism. (2) the test provides information on
the result of taking only a single dose of the substance.
A quantitative measurement of the rate of entry of an
absorbed substance into the body has been presented by Scholar
and Coda, 1954, for example, who determined the rate of
xx i
absorption of deuterium oxide in human subjects. If absorp¬
tion is occurring at a constant rate A gm. per minute into
the body fluids of volume V litres, and c gm. per litre is
the concentration in body fluids at a given time t minutes
after absorption begins
A= Kc + Vdc/dt.





The substrate concentration in the body fluids can only
be taken as a measure of the rate of absorption when the value
of the term Kt/V is large (Parsons, 1968). The rate of dis¬
appearance from the extracellular fluid after intravenous
injection provides a measure of the kinetics of disposal.
Assuming (A=0) the term Kt/V for various values of t
can be discovered from the relationship
Kt/V= In (Co/Ct)
where Ct= concentration of the substance at time t.
Co= initial uniform concentration after injection.
Radioactive methods One of the earliest uses of isotopically
labeled substances in biological studies gave information on
absorption in human subjects. In 1934 Hevesy and Hofer caused
xxii
human subjects to drink deuterium oxide (heavy water) and
found that it appeared in the urine in 30 minutes. Since
this time, radioisotopes have been used to facilitate toler¬
ance testing. In 1953, Schilling introduced a method for
measuring the absorption of vitamin B12. The radioactive
oral dose was given together with a large non-radioactive
parenteral injection of the vitamin which reduced retention
of the radioactive vitamin in the body. This method was
refined by Brain and Booth (1964) who gave tritium labeled
pyridoxine orally together with increasingly large non-radio¬
active doses of the vitamin in order to determine the loading
dose required to ensure minimal retention of radioactivity in
the body. This method depends upon the assumptions that the
radioactive label is not displaced from the molecule, the
loading dose does not alter the normal physiological activity
of the intestine and that the radioactive and non-radioactive
molecules behave identically.
Total body counting has been used for radioactive sub¬
stances with - emissions. Attempts have been made to measure
iron absorption by this method but difficulties have been
encountered in the relative efficiency of counting the radio¬
active iron which is in the gut and that distributed throughout
the body (Pollack et al, 1966).
Direct Methods
Intubation of the intestinal tract. In 1934, Miller and Abbott
xxiii
introduced a double lumen tube with a terminal balloon into
the human intestine and were able to sample from an opening
proximal to the balloon. Subsequently, a triple lumen tubs
was advocated (Abbott and Miller, 1936), which permitted
sampling from an area isolated between two balloons. However,
difficulties arose because inflation of the balloon often
caused colicky abdominal pain with possible alteration of the
local circulation and leakage around the balloon could not be
excluded.
Blankenhorn, Hirsch and Ahrens (1955) suggested a fine
polythene tube (external diametre 2mm) should be allowed to
transverse the entire intestine and samples could be taken at
varying levels following oral administration of a meal con¬
taining a marker substance. In 1961 Schedl and Clifton allowed
a tube with a blocked lumen 20-30 cm. along its length to pass
from the mouth to the anus. The test substance was perfused
from the oral end through an outlet and sampled more distally
by a portal in the anal end of the tube. The introduction of
a double lumen (Holdsworth and Dawson, 1964) and triple lumen
tubes (Cooper etal, 1966) have avoided the necessity of
waiting for the tube to pass along the full length of the
intestine. Absorption can be calculated from a knowledge of
the delivery rate of the infusion pump (R) and an analysis of
the inflowing and outflowing materials as follows:-
Let G= concentration of substance being infused.
M= concentration of marker substance.
g= concentration of aspirated test substance.
m= concentration of aspirated marker.
xxiv
assuming a steady state,
Rate of absorption per minute = RG-vg
where vml/min = rate of passage of fluid leaving past the
sampling port.
V= RM/m ml min. 1
Rate of absorption = R(G- gM/m) mgm.min. ^
These methods have been used to study the absorption of
many substances (Duthie, 1967). They measure the disappearance
of a substance from the intestinal lumen but not its passage
into the subcellular region or blood and lymphatics. A thirty
minute period of equilibration is required and it is an open
question whether the intestine under these conditions is in a
physiological state. These methods also rely on a non-absorb-
able marker like polyethylene glycol which is assumed to
travel down the intestine at the same rate as the test sub¬
stance. This subject has been fully reviewed by Smyth (1961)
and Dawson (1965).
Isolated loops A few experiments have been performed with
human small intestine isolated during a surgical procedure.
For example, the transport of water and electrolytes (Atwell
and Duthie, 1964; Schloerb and Lukert, 1963) and glucose,
butyrate, methionine have been studied. (McColl and Nissim,
1965). Unknown factors are the trauma of the operation and
the effect of anaesthesia.
xxv
Conclusion No single method, or parameter is adequate to
understand intestinal absorption in man. The choice of
methods will depend upon the information that the investigator
seeks. Despite all efforts, for many substances, final
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CHAPTER I
THIAMINE ABSORPTION IN NORMAL SUBJECTS
Introduction and background
Many different approaches in various animal species have
been used to investigate the sites and mechanism of thiamine
absorption. The resulting picture is confused and incomplete
and much still remains to be done. The methods used to
investigate the absorption of thiamine in man have often been
inadequate because of the limitations of methodology and no
reliable single test has been developed which can be used
routinely.
The pattern of absorption of substances from the small
intestine depends upon three factors. These are firstly, the
mechanism of absorption, whether active or passive; secondly,
in the case of active transport, the distribution of this
mechanism in different segments of the intestinal mucosa;
and thirdly, the relationship between the rate of absorption
and the rate of transit along the gut. (Booth et al, 1963).
The site and amount of absorption in animals
This was first investigated by Da Silva and Ivy, 1961,
using a chronic Thiry fistula in the jejunum or ileum in the
dog and determining thiamine by the fluorometric method
described by Burch et al, 1952. In both approximately 30%
1
2
of the IOmgm. dose of thiamine was absorbed in one hour.
Evidence indicated that under the conditions prevailing in
the Thiry fistula destruction of thiamine did not occur at
least during the first 30 minutes and they also rejected the
possibility of excretion of thiamine into the loop altering
the dose. The amount absorbed did not vary significantly
from day to day.
These findings are in contrast to those of Polin et al,
1964 who investigated absorption in three week old chicks by
adding thiamine-2CI4-hydrochloride to the diet at a concen¬
tration of either 4.8 mgm/Kgm. or 112 mgm/Kgm. After four
days the animals were sacrificed, the radioactivity in
various lengths of intestine counted and thiamine estimated
by the thiochrome method (Snell and Snell, 1953). At the
lower dose, the concentration in the duodenum was higher than
in the upper or middle third of the small intestine. However,
the amount found in the animal's crop was not stated, the
time interval from the last meal nor the effect of sacrifice
on distribution along the intestine determined. At the
higher dose, the lowest concentration was found in the duo¬
denum.
The progressive increase in concentration of the vitamin
found in sections distal to the duodenum was explained by
re-excretion into the intestine via the bile or reversed
secretion across the intestine. This conclusion, however,
was not supported by measurements of the concentration of
3
thiamine in the bile nor was there any estimate of the
expected accumulation of unabsorbed thiamine at the distal
end of the intestine.
The suggestion that the lower intestine may secrete
thiamine at high dose levels was first made by Gassmann and
Ketz, 1961, who presented evidence suggesting that at high
blood concentrations, thiamine can pass from the circulation
into the lumen of the intestine. How important this is in
terms of the net absorption may be ascertained by giving
radioactive thiamine paranterally and determining the amount
appearing in the faeces. Middleton and Morrison, 1962,
working with weanling Winster rats gave doses of 5 jigm. ,
10 pgm., and 20 pgm. of 35S-thiamine subcutaneously and
found 1.3+ 0.5%; 1.6+ 0.3% and 2.0+ 0.3% respectively
during the succeeding four days. Iacono and Johnson, 1957,
injected 1-10 mgm. intraperitoneally into Sprague Dawley rats
and recovered only 0.8% - 1.6% in the faeces in 24 hours.
Similar results were found by McCarthy et al., 1954 and
Draper, 1958 who recovered 0.3% - 1.4% when 120 pgm. of 35S-
thiamine was given intraperitoneally to six young rats.
These findings were shown to resemble those found in man
where the faecal excretion was measured for seven days after
an intravenous injection of 20 mgm. of thiamine and the faecal
levels of thiamine were found to be hardly affected (Shina-
zoid and Katsura, 1965). The blood levels following an
intravenous dose will be far higher than after a comparable
oral dose and consequently you might expect the passage into
the intestine to be greater.
The site of thiamine absorption was investigated in
Wister strain of rats by Middleton and Grice, 1964. In the
first experiments, rats weighing 200-250 gra, were given
20 jigm. of 35S-thiamine by stomach tube. The animals were
anaesthetised with ether prior to exsanguination at intervals
after the oral dose up to 24 hours. At laparotomy, ligatures
were tied around the lower end of the oesophagus, the duo¬
denum near the pylorils and the ileum near the ileocaecal
junction. The small intestine was divided into four approx¬
imately equal ligated segments. The percentage of the oral
dose found in a particular area was measured and the total
amount absorbed prior to sacrifice, was determined by sub¬
tracting the amount remaining in the intestine from the dose
given. Within the first half hour, thiamine was found to be
present throughout the intestinal tract and 32.9% of the
oral dose had already been absorbed. During the second hour,
a slight increase in the percentage of radioactivity present
in the lower ileum was noted while significant decreases
occurred in the more proximal portions. 71% of the admin¬
istered thiamine had been absorbed at the end of two hours,
and 88% after six hours when only very small amounts could
be removed from the large intestine. In a second series of
experiments, it was shown that removal of up to 70 cm. of
ileum did not influence the absorption of thiamine as shown
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by faecal analysis.
Consequently, work in different animal species suggests
that thiamine absorption can occur throughout the ileum but
is maximal in the proximal small intestine. The amount of
destruction in this region before most of the thiamine has
been absorbed is uncertain and the importance of re-excretion
into the lower ileum occurring at physiological dose levels
remains in doubt.
The site and route of absorption in man
That thiamine absorption occurs primarily in the upper
small intestine in man has been inferred from the rapid rate
of absorption. The findings of Bean et al, 1951, in two
cirrhotic subjects with unusual connections between the
portal vein and a superficial abdominal vein, however, tend
to confirm this conclusion and suggest that thiamine is
probably absorbed via the portal system. Using the thio-
chrome method they simultaneously measured the serum levels
in the 'portal vein' and the systemic venous circulation
following a 5.0mgm. oral dose of thiamine. A number of
unanswered questions leave doubts as to the correct inter¬
pretation of the data. These include the fact that the com¬
munication was only confirmed in one patient, the assumption
that thiamine is in a form both in the portal vein and after
passage through the liver which can be measured by the
thiochrome method and that the absorption in patients with
6
cirrhosis is the same as in the normal individual. However,
the results suggest that absorption is maximal during the
first three hours and that this occurs via the portal system.
The influence of gastric secretion on thiamine absorption
It has been suggested that thiamine deficiency may pro¬
duce achlorhydria which subsequently interferes with absorp¬
tion of thiamine. However, investigations by Shay et al,
1946, in rats and Gildea et al, 1930; Elson, 1935 and Rafsky
et al, 1947 in man failed to demonstrate abnormalities in
gastric secretion in thiamine deficiency or any correlation
between achlorhydria and reduced thiamine absorption. Wang
and Harris, 1939 and Brummer and Markkanen, 1960 measuring
daily urinary excretion of dietary thiamine have found
reduced excretion in achlorhydric subjects. The influence
of achlorhydria on thiamine absorption warrants further
investigation using radioisotopes.
Absorption from the large intestine
Less than 2% of physiological doses of thiamine hydro¬
chloride given by enema is absorbed in roan (Alexander and
Landwehr, 1946; Campbell and Morrison, 1963). These con¬
clusions are supported by work in rats by Middleton and
Grice, 1964. Little absorption seems to occur from the
large intestine even when large doses are given. The fate
of small amounts remaining from a physiological oral dose
after passage through the small intestine has not been
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directly investigated and the importance of breakdown of
thiamine by large bowel bacteria prior to absorption is not
known.
The evidence suggests that thiamine absorption is
probably maximal in the upper small intestine but that
absorption occurs throughout the small intestine. The
influence of achlorhyaria on thiamine absorption requires
further investigation and the degree of breakdown of thia¬
mine by intestinal bacteria prior to absorption has not been
estimated in man. The absorption occurring in the large
bowel following an oral dose seems to be very limited and
probably plays little part under normal conditions.
General Materials and Methods
Radioactive material. All of the thiamine preparations were
supplied as the hydrochloride except where it is specifically
stated that thiamine propyl disulphide was used. 35S-
thiamine was obtained from the Radiochemical Centre, Amer-
sham. The radioactive material used orally had a specific
activity of 177 mc/ gm. and was found to be radiochemically
pure when tested in the three chromatographic systems
described below. The solid material was dissolved in dis¬
tilled water, 100 jic (10 doses) dispensed into each ampule,
freeze dried, and stored at -20°C. It was reconstituted by
adding 10 ml of distilled water. In a few experiments,
radioactive thiamine was used intravenously. This material
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was supplied in aqueous solution pH 5; it had a specific
activity of 12.0 pc/ral. and analysis showed it was more than
90% radiochemically pure. The non-radioactive thiamine was
•applied in ampules containing 100 mgm. in one ml-by Roche
Products Ltd., England.
Method for the study of absorption of 35S-labelled thiamine.
The radioactive material was diluted with non-radioactive
thiamine so that each test dose contained from 1.0 mgm. to
200 mgm. and 10 pc of radioactivity dissolved in 20 ml. of
water. A quantity of the solution from which the test dose
was prepared was used as a standard. The test dose was given
orally to subjects after an overnight fast, and in some
experiments a parenteral injection of non-radioactive thia¬
mine was given immediately before the oral dose. The
standard test referred to later includes both a 1.0 mgm. oral
dose of radioactive thiamine and a parenteral injection of
200 mgm. non-radioactive thiamine given at the same time as
the oral dose. Absorption was assessed by measuring the
urinary radioactivity during the following 24 to 72 hours.
Arterial blood was collected via a Cournard needle in vacu-
tainersR at 0, 3, 6, 10, 20, 30, 40, 60, 90, 120, 150 and
180 minutes or more frequently. Urine was collected hourly
for the first five hours and then after 12, 24, 48 and 72
hours. Samples were counted in a Packard Tricarb Scintil¬
lation counter using 0.8 gm. per cent of 2-5 diphanyloxazole
and 0.005 gm.per cent of 1,4-bis(2(phenyloxazolyl)) benzene
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dissolved in toluene as the liquid scintillator. The samples
were prepared by adding 1.0 ml. of serum or urine to 3 ml.
hyamine chloride, 1.5M solution in methanol, and adding 10ml
liquid scintillator. IOjuc of the test dose was added as an
internal standard to each sample.
Accuracy of counting of radioactivity in urine. Known amounts
of 35S--thiamine were added to three equal volumes of urine to
give final thiamine concentrations similar to those encoun¬
tered in the tests on subjects. The urines contained approx¬
imately 8.0 nc/ml, 0.8 nc/rnl. and 0.0 4 nc/ml. The urines were
shaken and twenty samples taken from each (only ten from
0.04 nc/ral. urine) using the same pipette which was washed
between samples. Liquid scintillator was added by pipette
and each sample was counted twice. The results are shown in
Tables la, lb, and 1c. It will be seen that variation due to
sample preparation and counting is extremely low and well
within the experimental error introduced by other factors.
Modified extraction procedure for urinary radioactivity. The
method used was the phenol extraction procedure of Iacono and
Johnson, 1957 modified following the experiments described
later in this chapter, page 65. The inorganic salts were
first removed by the phenol extraction procedure of Crammer,
1948, as these were known to cause streaking and tailing of
radiometabolites on chroraatograms with the various solvents
10
Table la. Duplicate counts of twenty specimens
prepared from the same urine sample
a. At the concentration of 8.3 nc*/ml.
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Table lb. Duplicate counts of twenty specimens
prepared from the same urine sample
b. At the concentration of 0,76 nc/rol.
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Table lc. Duplicate counts of ten specimens pre¬
pared from the same urine sample
c. At the concentration of 0,04 nc/ml.
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.0406 ± .0003 nc/ml
13
employed. The extraction was carried out in a separating
funnel by adding an equal volume of water-saturated phenol
to the urine, the mixture shaken vigorously, and allowed to
separate overnight at 4°C. The phenol layer was then drained
off and washed several times with water to remove the last
traces of salt. Twice the volume of diethyl ether and water
(40II) was then added to the phenol extract and the mixture
shaken. Within minutes, the water phase containing the
metabolites settled to the bottom of the funnel and was
drained off. The ether-phenol mixture was washed several
time3 with small volumes of water and the washings added to
the original extract.
In order to eliminate still more of the urinary solids
and yet retain the radioactivity in solution, the urinary
extract was concentrated in vacuo at 35°C. to about 3 ml.
Approximately 35 ml. of absolute ethanol was added and the
volume again concentrated to four ml. The resulting precipi¬
tate did not contain any radioactivity and was discarded.
The method was consistently found to remove approximately
90% of the radioactivity present in the original sample.
Descending chromatography was performed on Whatman no.l paper
using IJ-propanol-water-IM acetate buffer pH5 (70 :20:10), the
upper phase of sec-butanol/water as solvents. The papers
were scanned in a BTL Radioactive Chromatogram Scanner and
radioautographs were prepared.
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Kadioautographs. For the preparation of autoradiographs,
the dried paper chromatograms were marked in all four
corners with radioactive ink and then placed in contact with
Gavert non-screen X-ray film in a 14 x 17 in. Wolf-Kirshner
x-ray film exposure holder and placed under a press in the
dark; the film was exposed to the chromatogram for up to
three months, depending upon the amount of radioactivity.
The films were developed in a conventional manner using
Kodak developing facilities.
1dentification of Thiamine Compounds on Paper Chromatograms.
A. Thiochrome test. After drying the chromatograms at room
temperature thiamine and its esters present on the paper
were converted to the corresponding thiochromes by the
method of Siliprandi & Siliprandi, 1954; this test will
detect l.Ojugm. thiamine.
Bioautography. was used to check the biological activity
of the thiamine extracted from the urine and small intes¬
tinal juice. Some chromatograms were not sprayed but were
scanned and the radioactivity eluted with 3 ml.distilled
water. The ability of the eluate to support the growth of
O.danica, which requires intact thiamine (Heinrich, 1955;
Baker, et al, 1964), was compared with a control consisting
of an equivalent area cut from the same chromatogram. The
method of Baker etal, 1964, was used for thiamine assay.
Following incubation, the material was centrifuged at 3,000
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revolutions per minute for 30 minutes and subsequently washed
by centrifuging after resuspension in two aliquots of 20ml.
sterile distilled water. The radioactivity could not be
washed from the organisms. The organisms were finally sus¬
pended in gel-scintillator and the radioactivity present
counted by well-scintillation counting.
C. Separation of radioactive compounds. To confirm that
complete separation had been achieved, two chromatograms
were run in each of the three solvent systems and the radio¬
activity corresponding to thiamine eluted as above. Each of
the elutes was then re-run in a different chromatographic
solvent system and produced a single spot at the same Rf as
thiamine. The radioautographs also showed a single discrete
spot.
Hepatic vein catheterization Catheterization of the
hepatic vein was carried out according to the method of
Leevy and Gleidman, 1958 using the facilities shown in
Figure 1. Studies were performed in the basal state. With
sterile precautions, a right or left basilic vein was
exposed, and the largest catheter accepted by the vein,
connected with a three-way stopcock, was inserted and ad¬
vanced to the right atrium. A constant slow drip of saline
solution containing 50 mgm.of heparin per litre was allowed
to flow through the catheter to prevent intraluminal clot¬
ting. The catheter was introduced under fluoroscopic
16
FIGURE 1. Catheterization Room
t
17
control into the inferior vena cava by being turned so that
the curved tip pointed right and anteriorly. The tip was
guided into the right hepatic vein and advanced to the
wedged position in the small hepatic venule. The position
of the tip of the catheter was confirmed by observation of
the pressure curve and the injection of contrast medium.
Withdrawal to the 'free' position permitted blood sampling
from the hepatic vein. A Cournand indwelling arterial
needle was introduced into the femoral artery. Hepatic
blood flow was determined by the Fick principle using indo-
cyanine green (ICG) (Leevy et al., 1962).
Umbilical vein catheterization was performed using the
method of Lavo*ie et al., 1966 by a surgeon in the operating
theatre. Under local anaesthesia, a 5 cm. long cutaneous
incision was made half way between the xyphoid process and
the umbilicus. After dissection of the two layers of the
falciform ligament, the round ligament was identified,
laying on the peritoneum. It was then opened and dilated
with a Bakes dilator. A membrane closes the former umbil¬
ical vein at the portal junction and, when punctured,
allowed portal blood to flow back into the umbilical vein.
A ureteral catheter (size 8, nylon) was then placed via
the umbilical vein, into the right branch of the portal
vein. The position of the catheter is confirmed by the
injection of radio-opaque dye (Figure 2). A constant slow
FIGURE 2. Hepatogram obtained through transumbil¬
ical catheterization with the end of the catheter
in the right portal vein.
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drip of normal saline containing 50 mgm.of heparin per




Investigation of test conditions. The 24 hour excretion
of radioactivity when ten control subjects were only given
1.0 mgm.of radioactive thiamine orally was 6.1% (SEM +
0.64) but if the oral dose was preceded by giving 300 mgm.
of non-radioactive thiamine intravenously 43 hours before
the excretion of radioactive thiamine rose to 15.3% (SEM +
2.63). This difference is highly significant. (t = 4.26,
p<0.01). (Table 2).
The standard test. The effect of varying the size of an
intravenous dose of non-radioactive thiamine given at the
same time as the oral dose of radioactive material was
studied and the optimum amount for this intravenous flush¬
ing dose was found to be 200 mgm. This dose ensured
maximal excretion and will be referred to as the standard
test of absorption in this section (Table 3; Figure 3).
Giving thiamine to control subjects two days before they
received the standard test did not alter the mean urinary
excretion of radioactivity (Table 4). (t = 0.814; 0.2<
p < 0.5) .
The duration of the flushing dose
The duration of the flushing dose was investigated in
23
Table 2* Excretion of radioactivity (%) after 1.0 mgm, 35S-thiamine
hydrochloride orally before and after *saturction in controls















* Subjects saturated with 300 mgm. thiamine hydrochloride i.v.
48 hours before test.
FIGURE 3. Twenty-four hour urinary excretion of
radioactivity after 10 mgm. 35S-thiamine dydro-
chloride (THC1) orally with varying amounts of non¬




Table 3. Twenty-four hour urinary excretion of radioactive
thiamine by normal subjects
The effect of injecting varying amounts of non-radioactive
thiamine at the time of administering 1.0 nigra. radioactive
thiamine by mouth on the excretion of radioactive thiamine
in the urine.
Intravenous dose of non- Urinary excretion of radioactivity
radioactive thiamine Zoral dose*
mcym .
■ Before loading After loading**
0 6.1 i 0.64 (10) 15.3 ± 2.63 (6)
23 35.0 ± 2.95 (5)
50 39.5 ± 3.18 (7)
100 51.7 ± 5.04 (9)
200 48.2 ± 4.54 (10) 54.1 ± 5.66 (10)
300 50.2 ± 3.66 (8)
*The results are expressed as the mean - SEM (n) Urine was
collected for 24 hours.
**Subjects given 300 mgm. thiamine i.v. 48 hours before test, and
a further dose of thiamine at tha time of the test.
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Table 4* Effect of saturation on results of standard oral test*
in control subjects











MEAN 48.2 MEAN 54.1
S.E. 4.54 S.E. 5.66
*Standard Oral Test - 1.0 mgm. thiamine - 35S HC1 orally
200 mgm, thiamine hydrochloride intravenously. Saturated
as before, see Table 3.
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six subjects by incorporating radioactive thiamine (5.<g
in the 200 mgm. parental injection of non-radioactive
thiamine. The results following intravenous and intra¬
muscular administration are shown in Figures 4, 5, and 6.
The rate of disappearance from the serum was not exponen¬
tial but a straight line relationship could be obtained if
the serum level was plotted against log(log) time.
Eighty-eight per cent of the intravenous dose was
recovered during the first 24 hours and 90% after the
radioactive thiamine was given intramuscularly to the same
subject. (Figures 4 and 5). Four other subjects excreted
more than 93% of an intravenous dose in 24 hours. Conse¬
quently, it seems that practically all of the oral dose
absorbed, once it reaches the blood stream, will probably
be excreted during the first 24 hours, under the conditions
of the standard test.
Adequacy of the flushing dose
The adequacy of the 200 mgm. flushing dose was tested
further by varying the time of the flushing dose or main¬
taining a high blood level of non-radioactive thiamine
during the first 16 hours by repeated injections but this
had a negligible effect on the total urinary recovery
(Table 5). When the standard test alone was repeated in
four subjects, the following results were obtained:
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FIGURE 4. The radioactivity in serum and urine after
administration of radioactive thiamine hydrochloride









FIGURE 5. The radioactivity in serum and urine after
administration of radioactive thiamine hydrochloride
(THC1) intramuscularly on a different occasion to the
same control subject as in figure 4. 200 mgm. of
non-radioactive thiamine hydrochloride was given along
with the radioactive thiamine.
%INTRAMUSCULAR35S-THIAMINEHC1EXCRETED SERUML VELNANOCURRI S/ L
FIGURE 6. The rate of removal of radioactivity from
the serum after 5.0 mgm. of 35S-thiamine hydrochloride
(THC1) and a 200 mgm. of non-radioactive thiamine
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Table 5, Effect of varying the time of the initial flushing
dose andgiving additional intravenous flushing doses
Subjects were given two tests: First* and Second** and
received 300 mgm. non-radioactive thiamine intravenously
48 hours before each test.













*First test ■> 1.0 mgm, radioactive thiamine orally and 200 mgm,
non-radioactive thiamine flushing dose intravenously
at the same time*
**Second test » Subjects 1-3 same as first test with additional
100 mgm. flushing doses at 2, 6 and 12 hours after
oral dose*
4: - same as first test with
additional 200 mgm* at 4 hours.
5: - received 200 mgm. i.ra, only at
time of oral dose.
6i - uo flushing dose at time of oral
dose but 2CG mgm. i.v. 1 hour
after.
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46.0%, 38.4%; 49.0%, 54.0%; 58.4%, 54.7%; 60.0%, and
62.7%.
Effectiveness of the Flushing Dose with Larger Oral Doses
The effectiveness of the 200 mgm. flushing dose when
used with larger oral doses of radioactive thiamine, was
tested. Twenty-four control subjects were given either
1.0 mgmv 5.0 mgm, or 20.0 mgm. of radioactive thiamine
orally together with 200 mgm. of non-radioactive thiamine
intravenously. The results were compared with those
obtained in the same subject, given the same test as before,
but with additional 100 mgm. intravenous injections of non¬
radioactive thiamine at 4 hours, 9 hours, 12 hours and 24
hours after the oral does. Urine was collected for 72 hours
after each test (Table 6; Figure 7). A one-way analysis of
variance computed on the difference between the two tests
showed that giving extra flushing doses did not signifi¬
cantly alter the excretion. P[F+ 0.704; d.f.(2,22)] = 0.99.
The giving of additional flushing doses did not significantly
increase the total excretion of activity nor alter the
pattern of excretion. Consequently, a 200 mgm. flushing dose
was used with all oral dose levels. Approximately 45.0% of
a 1.0 mgm., 34.0% of a 5.0 mgm. and 25.0% of a 20 mgm. oral
dose is excreted in the urine in the first 72 hours.
Attempts were made to count the radioactivity remaining in
a divided, four day, stool collection by oxidising the
37
Table 6. The effect of giving additional intravenous flushing
doses to control subjects receiving 1.0 tngra,, 5.0 mgm.
or 20,0 mgm. of radioactive thiamine orally
Subjects were given two tests: First* and Second**.



































































*First test 1.0 ragm., 5.0 mgm,, or 20.0 mgm, radioactive thiamine
orally and 200 mgm, non-radioactive thiamine flushing
dose intravenously at the car.a tine.
**Second test Same as for first test with additional 100 ragm. flushing
doses at 4, 9, 12 and 24 hours after oral dose.
Urine was collected for 72 hours.
FIGURE 7. The effect of
venous flushing doses to




































10 20 30 40 50 60 70 80 90 100
ADDITIONAL FLUSHING DOSES
% ORAL DOSE EXCRETED
40
thiamine present with boiling nitric acid and then precipi¬
tating the sulphate as barium sulphate. However, the mass
of radioactive thiamine remaining would have been extremely
small and no reliable results with recovery experiments
were obtained.
Figure 8 shows the cumulative excretion of radioactiv¬
ity after 1.0 mgm. 35S-thiamine orally and 200 mgm. flushing
dose in a control subject who previously received 300 mgm.
thiamine intravenously 48 hours before. Excretion was
maximal between 1-2 hours during which time 41% of the dose
was excreted. By 12 hours, excretion was almost complete,
3% being added in 12-24 hours, and further small amounts
thereafter (3.4% in 24-48 hour and 4.1% in the 48-96 hour
periods after which excreted radioactivity was too small
to be measured accurately). Various mathematical trans¬
formations of the data were attempted and it was found that
when the amount excreted (in mgm. y), was plotted against
log(log) time, x, an approximate straight line was obtained
which could be described by the equation y= 0.581 + 0.4247x
(Figure 9).
A comparison of the patterns of excretion obtained at
different oral dose levels is shown in Figure 10. Three
subjects were given 1.0 mgm., 5.0 mgm., and 20.0 mgm. of
radioactive thiamine orally and a 200 mgm. flushing dose.
The maximal period of excretion occurred at approximately
FIGURE 8. The cumulative urinary excretion of radio¬
activity after 1.0 mgm. of 35S-thiamine hydrochloride
(THC1) in a control subject; 200 mgm. of non¬
radioactive thiamine was given intravenously.
 
FIGURE 9. The relationship between time and the
amount of radioactivity excreted following 1.0 mgro.







FIGURE 10. Excretion patterns with different oral
doses of radioactive thiamine hydrochloride (THC1).
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the same time and the pattern of excretion is very similar
in all three subjects. The mass of radioactive thiamine
excreted in one hour was always extremely small when com¬
pared with the amount of the flushing dose excreted and
never exceeded 0.27 mgm. The hourly outputs at the
different dose levels did not increase proportionately
with the size of the oral dose. During the first three
hours, at 1.0 mgm. oral dose, the hourly excretions were
0.15 mgm., 0.13 mgm., 0.13 mgm.; at 5.0 mgm. oral dose they
were 0.12 mgm., 0.24 mgm., 0.18 mgm., and at 20 mgm. they
were 0.21 mgm., 0.27 mgm., and 0.23 mgm. At higher doses,
however, thiamine continued to be excreted at a higher rate
for longer.
The rate of appearance of radioactivity in the serum
and the hourly urinary excretion of thiamine was tested in
twelve control subjects after 5.0 mgm. 35S-thiamine (IQjic)
orally and 200 mgm. flushing dose. The urinary excretions
resembled the pattern shown in Figure 10. Arterial blood
samples were taken at 0,3, 6,10, 20,30,60,90, 120, 150 and
180 minutes after the beginning of the test and the results
are shown in Figure 11.
It will be seen that radioactivity could be detected
in the serum as early as three minutes after administration
of the oral dose and the maximum concentration of radio¬
activity in the serum was reached at approximately ninety
FIGURE 11. Arterial serum radioactivity and cumulative
urinary excretion in control subjects after 5.0 mgm.
35S-thiamine hydrochloride (THC1) orally together with
a 200 mgm. intravenous flushing dose.





minutes after the oral administration. The level of radio¬
activity in the serum was reached at approximately ninety
minutes after the oral administration. The level of radio¬
activity in the serum will be seen to parallel the amount
excreted in the urine suggesting that urinary excretion is
a sensitive indicator of changes due to the absorption of
the oral dose under the conditions of the test. (Figure 10)
Comparison of rates of excretion of oral and flushing doses
of Thiamine. Distribution of thiamine in extracellular
fluid.
It was possible that the decline in the rate of excre¬
tion of urinary radioactivity, and the fall in serum level,
two hours after an oral dose given along with a parenteral
flushing dose did not reflect the absorption of radio¬
active thiamine from the intestine. It could have been the
result of a fall in the total blood level of thiamine due
to rapid excretion of the flushing dose.
This possibility may be excluded by determining at any
given time the concentration of thiamine in the serum due
to the flushing dose and the concentration due to the
orally administered thiamine. An estimate of these levels
may be obtained by giving a subject a 5.0 mgm. oral dose
of non-radioactive thiamine together with a labelled
flushing dose. The test can be repeated in the same sub¬
ject using a labelled oral dose and a non-radioactive
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flushing dose. The arterial serum concentration of thia¬
mine expressed as mpgm./ml. obtained using this technique
are shown in Figure 12. It will be seen that the maximal
level of thiamine due to the flushing dose occurs imme¬
diately following injection after which there is a steady
decline in the serum level. In contrast to this, the
thiamine absorbed from the orally administered dose does
not reach its peak value until 90 minutes after administra¬
tion. At no time does the renal mechanism for the removal
of thiamine seem to be saturated. At the time of maximum
absorption of the oral dose, the serum thiamine level due
to the flushing dose is still one hundred times that
produced by absorption from the intestine. Consequently,
the patterns of radioactivity obtained in the serum and in
the urine following a radioactive oral dose probably
represent the true profile of absorption and the frequency
with which labelled thiamine present in the oral dose under¬
goes metabolism or storage within the body is low.
Distribution of the administered thiamine within the body.
It is possible to determine the distribution of thia¬
mine within the body fluids. Knowing the amount of thiamine
given intravenously, and the approximate amount excreted
after a given time, and the circulating volume, it is
possible to predict the level that would be obtained if
FIGURE 12. Estimated concentration of thiamine in
arterial blood due to absorption from the oral dose
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thiamine were confined to the plasma volume or distributed
throughout the total body water. In Table 7, the measured
levels are compared to the predicted levels in the serum
following a 200 mgm. 35S-thiamine hydrochloride labelled
flushing dose.
It will be seen that after the initial period of
mixing, the predicted results agree most closely with the
observed results if it is assumed that the thiamine is
distributed throughout the total body water.
Control subjects v/ere shown to excrete approximately
35% of a 5.0 mgm. oral dose in the urine when given
together with a 200 mgm. parenteral injection, however, the
rise in serum concentration of radioactivity observed was
comparatively small. To investigate the reason for this,
rough calculations were made using mean figures obtained
from the 12 control subjects studied. (Figure 11). The
calculations indicate that the thiamine is partially dis¬
tributed between the plasma and the extracellular fluid and
that the observed values are within the range expected
allowing for the rate of absorption, the rate of excretion
and possible distribution of thiamine. (Tables 8 and 9)
Route of absorption
The route of thiamine hydrochloride absorption was
investigated in 5 alcoholics subjects without evidence of
malnutrition or liver disease, and 5 with cirrhosis, 2 of
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Table 7. Measured aud predicted thiamine concentrations



























*aVi m bony water.
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Table 8. Estimated serum concentration after 5,0 ragm. of
35S-thiamine orally and 200 mgm. non-radioactive
flushing dose using mean values found in the control groups
A. Level at end of one hour.
Percentage dose absorbed A 5% 240 jigm.
Percentage of absorbed oral
dose + flushing dose excreted * 50% « 120 jigm. (of oral dose)
Therefore, amount remaining
in body A 120 ^tgm.
■ 120,000 mjngm.
If distributed in plasma (3,000 ml,) - 40 mjigm./ml.
If distributed in extracellul ar
fluid (12,000 ml.) ■ 10 mpgm/ml.
If distributed in Total body water - 2,5 nyjgm/ml.
B, Level at end of three hours.
Percentage dose absorbed «* 10% ■ 500 pgra.
Percentage excreted » 78% - 390 jigm.
Therefore, amount remaining
in body » 500-590
- 110,000 gyigm.
If distributed in plasma volume = 37 m
If distributed in extracellular water « 9,1 mpgm/ral.
If distributed in total body water « 2,3 mjjgm/ml.
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Table 9. Summary of results - comparison of observed and
predicted serum thiamine concentrations depending
upon distribution within the body
Predicted concentrations mjugm/ral.
Time Average Plasma Extracellular Total
Observed alone fluid alone Body
serum conc. water,
hr. mygm/ral (31itres) (121itres) (481itres)
1 19.6 40 10 2.4
3 15.7 37 9.1 2.3
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whom had end-to-side portacaval shunts. Absorption studies
were carried out using combined umbilical and hepatic vein
catheterization in the 3 malnourished patients with
cirrhosis without shunts. Hepatic vein catheterization
alone was used to study intestinal absorption in the others.
The Fick principle was used for estimation of hepatic
blood flow, employing a constant infusion of ICG (0.3
mg/m /min), after a 10 mgm. loading dose of the dye (Leevy
et al., 1962). Five mgm. of 35S-thiamine hydrochloride was
given via a Rehfuss tube positioned in the duodenum prior
to catheterization. Blood samples were obtained from the
umbilical vein, hepatic vein, and femoral artery prior to
the receipt of thiamine or ICG, at 1 minute intervals for
10 minutes, and at 10 minute intervals for 2 hours for
measurement of ICG and radioactivity.
35S-thiamine was detected in hepatic venous blood 1
to 3 minutes prior to its appearance in arterial blood.
Hepatic venous radioactivity remained significantly higher
throughout the period of observation. In the patients
with portacaval shunts, 35S-thiamine was initially detected
in arterial blood and radioactivity was lower in hepatic
venous than arterial blood. (Figure 13) Observations
during simultaneous catheterization of umbilical and
hepatic veins first revealed radioactivity in the portal
vein, secondly in the hepatic vein, and finally in the
femoral artery (Table 10; Figure 14).
Table.10a.Radioactivity*inh paticein(IIV)andFemoralAr ery(FA)fter 5.0ragm.35S-thia lnehydrochloriderally2 0gm.fnon-ra ioactive









































































































































































































































































































FIGURE 13. Radioactivity in hepatic vein and femoral
artery after 5.0 mgm. of 35S-thiamine hydrochloride
(THC1) orally and 200 mgm. non-radioactive thiamine
intravenously in alcoholic subject and a patient with
a portal-caval shunt.
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FIGURE 14. Radioactivity in portal vein, hepatic
vein and femoral artery after 5.0 mgm. of 35S~
Thiamine hydrochloride (THC1) orally and 200 mgm.
non-radioactive thiamine intravenously in a control
subject.
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Development of Methods to Identify Radioactivity Present
in the Urine and Intestinal Contents after Oral Adminis¬
tration of 35S-labelled Thiamine.
It was possible that the orally administered thiamine
was being broken down in the intestine and that these
breakdown products were subsequently absorbed and excreted
giving an erroneous measure of thiamine absorption. To
investigate this possibility, methods were adapted so that
the radioactivity present in the urine and in the intes¬
tinal juice, under the conditions of the test, could be
identified.
Modification of phenol extraction procedure for thiamine
metabolites in the urine
The method finally adopted was a modification of the
phenol extraction procedure of Iacono and Johnson, 1957,
and has been described in the section on General Materials
and Methods. The modifications were introduced after the
following experiments had been completed.
Phenol extraction. The first step in the extraction pro¬
cedure was to remove inorganic salts by the phenol extrac¬
tion procedure of Crammer, 1948, as these were known to
cause streakihg and tailing of radiometabolites on chromat-
ograms with the various solvents employed. Experiments
were carried out with different volumes of urine containing
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varying concentrations of thiamine metabolites to deter¬
mine the optimum ratio of water-saturated phenol-urine
to be employed.
Adequate water-saturated phenol was prepared for the
experiment. A 12 hour urine specimen from a patient given
the standard test was thoroughly mixed and divided into as
many equal volumes as required which were placed in separ¬
ating funnels. Two ml. were removed to measure the total
radioactivity present in each. The designated amount of
water-phenol was added to each funnel, the mixture shaken
vigorously, and allowed to separate overnight at 4°C. The
phenol layer wa3 then drawn off, washed several times with
water to remove the last traces of salt, and a two ml.
sample taken for scintillation counting. Similarly, the
volume of the water layer was measured and its total
activity determined. This experiment was repeated many
times with urine samples from different patients and
results similar to those shown in Table 11 were always
obtained.
Recovery was not one hundred per cent because of
difficulties in quenching experienced in counting the
material and the low levels of activity in some of the
specimens. However, even at a urine-water-phenol of 5:1
good extraction was obtained but equal volumes of urine
and water-saturated phenol were used in the final method
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Table 11. Percentage of extraction of radioactivity with varying
amounts of water-saturated phenol/urine
No. Urine Total Volume Ratio % of Radioactivity
Volume Radioactivity phenol Urine/
(ml) in Urine added phenol phenol water
(nc)* layer
1 300 3,550 300 lsl 94% 1%
2 300 3,660 150 2:1 94% 3.4%
3 300 3,500 100 3:1 9o% 2,0%
4 58 390 58 1:1 98% 2.5%
5 58 418 46.4 5:4 93% 6.5%
6 58 350 34.8 5:3 93% 6.3%
7 58 345 23.2 5:2 92% 8.4%
ft
O 58 375 11.6 5:1 92.5% 9.0%
*nc ■ nanocurries
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to ensure maximal extraction.
The phenol extracts were pooled, divided into equal
volumes, and shaken with a mixture of diethyl ether and
distilled water in the ratio 40:1. Within minutes, the
water phase containing the metabolites settled to the bottom
of the funnel and were drained off. The ether-phenol mixture
was washed several times with small volumes of water and the
washings added to the original extract. This step in the
extraction procedure produced considerable concentration of
a large volume of urine. The results obtained when varying
ratios of phenol extract-diethyl ether and water 40:1 were
mixed with a fixed volume of urine, are shown in Table 12.
For maximal extraction, a ratio of diethyl-ether-water/
phenol extract of at least 2:1 was required.
In order to eliminate still more the urinary solids
and yet retain the radioactivity in solution, the urinary
extract was concentrated in vacuo at 35#C to about three ml.
Approximately 35 ml. of absolute ethanol were added and
the volume again concentrated to four ml. The resulting
precipitate did not contain any radioactivity and was dis¬
carded. This was determined by taking 0.1 ml. of urine
extract and counting in the scintillation counter.
Another 0.1 ml. was centrifuged at 3,000 rpm. for half
an hour and the supernanant counted. Both gave identical
results 47 nanocurries.
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Table 12, Percentage of radioactivity extracted with varying
ratios of phenolextract/diethyl ether and water 40s1
No, Vol, Total Volume % Radioactivity
Phenol Radioactivity diethyl ether/ Extracted
(ml) Phenol sample water added
(ml) water phenol
phase phase
1 100 3,430 200 91% 8.5%
2 100 3,360 100 4.5% 87,0%
3 100 3,120 25 1.4% ao.0%
4 20 341 200 97.0% 7.0%
5 20 360 150 95.0% 8.0%
6 20 304 100 97.0% 8.0%
7 20 270 50 98.0% 3.0%
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The method was consistently found to remove approx¬
imately 90% of the radioactivity present in the original
sample and an example of the results obtained is shown in
Table 13.
Demonstration of thiamine and its metabolites in the urine.
Five patients were given 300 mgm. of non-radioactive thia¬
mine hydrochloride intravenously 4 8 hours before the experi¬
ment. On the day of the experiment they received the stand¬
ard test of 1.0 mgm. oral radioactive thiamine hydrochloride
and 200 mgm. of non-radioactive thiamine intravenously.
Urine was collected in a brown bottle surrounded by a freez¬
ing mixture of ice and solid carbon dioxide (Drikold, ICI
Ltd.), during the periods of 0-1 1/2 hours, 1 1/2-3 hours,
3-12 hours. Following voiding, the urine was either anal¬
ysed immediately or stored at -20°C. The radiometabolites
were extracted from the urine using the modified phenol
extraction procedure. Descending chromatography was per¬
formed, the papers were scanned and radioautographs prepared
as described in the section of General Materials and Methods.
Thiamine was identified by the thiochrome test, chromato¬
graphy and bioautography as previously described. In three
subjects, 90% of the radioactivity excreted during the 0-12
hour period had the same Rf. as thiamine in all three solvent
systems and gave a positive thiochrome test. The eluted
radioactivity could not be washed from the cells. (Figure
15). In the fourth subject, during the period 1 1/2-3 hours
after the dose 90% of the radioactivity was due to thiamine
71
Table 13. Phenol extraction of 0-3 hour urine of a patient
given 1.0 ragra. 35-Sthiamine hydrochloride and
200 mgm. flushing dose
Urine + water - saturated-phenol
Urine volume - 250 ml.
total activity - 2.320 nc.
Phenol|Layer
volume ■ 190 ml.
radioactivity « 2240 nc
washed distilled water
Water Llayer
volume - 270 ml.




vol » 50 ml.
radioactivity 0.0 uc
Washed Phenol Extract
volume « 180 ml.




radioactivity » 2140 nc
Diethyl ether
volume ■» 300 ml.
distilled water — >.5 iui.
Ether phenol layer I
volume « 415 ml.





Efficiency of Extraction - 92%
FIGURE 15. Chromatogram of phenol extract of 0-12
hour urine in a patient given 1.0 mgm. of 35S-
thiamine hydrochloride (THC1) orally and 200 mgm.
of non-radioactive thiamine hydrochloride intra¬
venously.
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i 1 1 1 1 1 1 1 1 1 1
l-O 0>9 0'8 0-7 0-6 0-5 0-4 0-3 0-2 O-l O-O
Conditions of paper chromatography: developing
solvent = n-propanol/IUO/acetate buffer ph 5
(70: 20: 10:).
Scanning conditions: Slit 1.0 cm. Counting time
20 minutes.
Detecting Reagent: Mixture 2 parts 96% ethanol,
1 part 10% NaOH and 0.05 parts of 2.5% K3Fe (CN) 6.
A = URINARY EXTRACT
B = NON»RADIOACTIVE THIAMINE HYDROCHLORIDE
C = SCAN OF CHROMATOGRAM
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but this fell to 60% in the 3-12 hour period. No attempt
was made to identify the other radioactive compounds.
Extraction of radio-metabolites from small intestinal juices.
Two normal subjects were intubated following an overnight
fast using a 1.5 mm bore polyvinyl tube weighted at one end.
The duodenal-jejunal junction is approximately 90 cm. and
the ileo-caecal valve 350 cm. from the nose in adults (Blank-
enhorn, et al., 1955). Sampling in one subject was from
points 105 cm. and 195 cm. from the nose on two successive
days, i.e. from the jejunum and from the proximal ileum; in
the other, sampling was only from the proximal ileum. The
fasting subjects were fed a test meal consisting of "Human¬
ised Trufood" (Trufood Ltd., The Creamaries, Wrenbury,
Cheshire) and 5juc of 35S-thiamine with sufficient non-radio¬
active thiamine to give a final thiamine content of 1.0 mgm.
The small intestinal juice was obtained by continuous
sampling into a flask surrounded by a freezing mixture.
The volume of intestinal juice decreased considerably after
the third hour. Consequently, the observations relate to
the 0-3 hour period. the pH of the intestinal juice was
measured with a glass electrode and never rose above pH 6.1,
i.e. it was always within the range at which thiamine is
stable. This agrees with the findings of Watson and Paton,
1965. At the end of the experiment, gastrografin was intro¬
duced into the tube to check the position of the sampling
point. (Figure 16)
FIGURE 16. X-ray photograph showing the tube used
for sampling small intestinal juice in position.
The mercury bag is seen and the more proximal
sampling port identified with gastrografin.
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Twenty ml. of small intestinal juice were dialysed
against three 100 ml. portions of distilled water left
for 24 hours at 4#C. The dialysates were freeze-dried
and then dissolved in 30 ml. absolute ethanol. The
solution was concentrated in vacuo at 35°C. to about 4 ml.
and a sample chromatographed. Recovery experiments gave
100% recovery up to twice the concentration found in the
intestine. No radioactivity was detected within the sac
after dialysis and it was found that over 90% of the
radioactivity was identical, chromatographically, with
thiamine.
Invitro incubation of thiamine with gastric juice, bile,
and small intestinal juice
Gastric juice was collected from five control sub¬
jects undergoing maximum histamine test meals and bile
was obtained from four patients with T~tube drainage
following common bile duct exploration and gall-bladder
surgery. Samples drained into recepticles surrounded by
a mixture of ice and solid carbon dioxide (Drikold, ICI,
Ltd.). Rat bile was also obtained from 200 gm. Sprague
Dawley rats by cannulation of the bile duct. Jejunal
samples were obtained following a meal of Humanised
Trufood or low protein diet from three control subjects
intubated on six different occasions. The method of
intubation and collection of samples was as previously
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described. The level of sampling from the nose and the.
time after the meal was taken is summarised in Table 14.
10 ml. samples of gastric juice, bile or small intes¬
tinal juice were incubated at 37°C. with 0.12 mgm. (5.One.)
or 1.7 jagm. (70 nc.) of radioactive thiamine hydrochloride
for 4 hours, 8 hours, 12 hours and 16 hours. The samples
were then chroraatographed, subjected to the thiochrome
test and scanned with the BTL Radioactive Chromatogram
Scanner. In all cases, the radioactivity was present in
only one spot which gave a positive thiochrome reaction
and had the same Rf as thiamine in all three solvent
systems. Consequently, under the conditions of the test,
no breakdown of thiamine was detected up to 16 hours
incubation at 37°C.
The influence of renal disease on the excretion of absorbed
thiamine.
Eight patients with severe renal disease were investi¬
gated to determine the influence of renal impairment on
the standard test. The subjects were given either 1.0 mgm.
or 20.0 mgm. of radioactive thiamine orally and 200 mgm.
of non-radioactive thiamine intravenously. Absorption was
studied by the appearance of radioactivity in the venous
blood and the urinary excretion of radioactivity in divided
72 hour urine samples. Some, patients were given 200 mgm..
of thiamine intravenously alone containing 10 uc 35S-thiamine
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Table 14. Collection of samples of Intestinal juice from
different regions of the Intestine in three control subjects










I. A. 79.0 97.0 First hour 221 6.05 HT.*
Second hour 223 5.18
Third hour 91 5.17
B. 144 157 First hour 140 6.13 HT.
Second hour 172 6.04
Third hour 90 5.55
2. A. 60 60 First hour 248 4.42 Low
Prot,
Second hour 202 4.20 Low
Prot
Third hour 18 4.39 Low
Prot
B, 130 130 First hour 50 6.28 HT.
3. A. 120 160 First hour 55 5.86 HT,
Second hour 71 5.98
Third hour 63 5.90
189 250 First hour 45 6.29 HT,
Second hour 135 6.36
Third hour 29 6.32
*HT » Humanised Truefood.
**Prot, » Protein.
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to investigate the rate of clearance of the flushing dose
from the blood. The results are shown in Table 15. The
urinary excretion of radioactivity was markedly reduced
in some patients even after 72 hours of collection; the
lowest levels being associated with the most severe
degree* of renal impairment. The patients could not be
used as their own controls since normal renal function
never returned. However, the patients with creatinine
clearances greater than 35/4 0 ml./inin. excreted normal
amounts of radioactivity. Even in these patients, some
delay in the rate of excretion can be detected (Figure 17)
which increases as the renal function deteriorates. Venous
serum levels of radioactivity in these patients showed peak
values between 1-2 hours comparable to those found control
subjects but the serum levels remained elevated for a
longer period. This was associated with a delay in
excretion of the flushing dose (Table 16; Figure 18).
Since the peak concentration in the serum occurs approx¬
imately at the same time as in control subjects, delayed
excretion secondary to reduced renal function possibly
explains the reduced urinary excretion of radioactivity
rather than a decrease in intestinal absorption.




BloodCreatinine%Radi activity UreaClearanceExcr tedaft r mgm.%1.0m.2 .
1. 2. 3. 4. 5. 6. 7.
46MChronic
Pyelonephritis





Insulin Insulin Lasix Prednisone 5mgm.bid.
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4ral./min. 3ml./min. 8ml./rain. 6tnl./min. 29ml./rain. 27ml./rain. 30ml./rain. 31ml./rain. 32ral./min. 33ral./min. 43ml./min. 40ml./min.
8959ml./rain.
5.4% 27.6% 40.0% 24.3% 55.4% 43.1%
36.6% 16.7% 18.3% 32.3% 27.9%
FIGURE 17. Cumulative urinary excretion of radio¬
activity after 1.0- mgm. of 35S-thiamine hydro¬
chloride (THC1) orally and 200 mgm. non-radioactive







X- —xJ^29 ml/ m i n1 27 ml /min
• • 32 ml/ min
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TIME ( Hours)
Table 16. Urinary excretion of radioactivity after 200 mgm,
of 35S-thiamine intravenously in a control subject
and two patients with renal impairment
Time %200 mgm, IV dose Time %200 mgm, IV dose
(hr.) excreted (hr.) excreted
Control* Chronic** Hypertensive***
Pyelonephritis Renal Dis,
0-.5 3.8 5.6 0-1 1.6
.5-1 21.1 10.4 1-2 1.3
1-1.5 25.6 0.1 2-5 4.0
1.5-2 11.4 0.2 5-12 4.8
2-2,5 6.1 9.7 12-24 6.0
2.5-3 4.9 5.7 17.8







♦Creatinine Clearance - 120ml,/min.
♦♦Creatinine Clearance - 18ml,/min.
20ml./min.
♦♦♦Creatinine Clearance - 8ml./min,
6ml./min.
FIGURE 18. Cumulative urinary excretion of radio¬
activity after 200 mgm. of 35S-thiamine hydro¬
chloride (TEC1) intravenously in a control subject

















These investigations indicate that radioactive
thiamine can be used to study the absorption of this
vitamin in man. Analysis of small intestinal juice and
extraction of the radioactivity present in the urine,
shows that during the period when maximal absorption is
taking place, little breakdown of thiamine occurs in the
small intestine and that most of the radioactivity
obtained in the urine is thiamine which was unchanged
prior to absorption.
When a relatively large injection of non-radioactive
thiamine is given intravenously, the percentage excretion
of radioactivity rises from about 6.0% to over 50.0%.
Since the non-radioactive parenteral thiamine promotes the
urinary excretion of the labelled vitamin, it would seem
that the radioactive thiamine behaves similarly to the
non-radioactive thiamine during its passage through the
body. Increasing the flushing dose to 300 mgm. thiamine
does not produce any further increase in the percentage
urinary excretion of radioactive thiamine (Table 3; p<0.5)
and it would therefore seem unlikely that the flushing
dose is altering the normal physiological activity of the
intestine.
Although one control patient excreted 90.7% of the
oral dose within the first 24 hours, the mean excretion
for the group was only 54.1% (SEM + 5.66) and prolonging
the urine collection for nine days in one subject added
only a further 7.5%, The total thiamine content of the
human body has been estimated to be 30 mgm. (Takeda, 1947).
Evidence suggests that in man a subject with normal
circulating thiamine levels can develop symptoms due to
thiamine deficiency after three weeks on a thiamine free
diet. Leevy et al, 1965b, monitored the decline in serum
thiamine and urinary thiamine which occurred in an obese
29 year old woman during 188 days of starvation. Lassitude,
hypotension and hyperemesis developed in the third week
which was only relieved by intravenous thiamine. The
minimum daily requirement of thiamine in the adult human
has been estimated at between 0.23 mgm/lOOOcal and 0.66mgm/
lOOOcal (Williams et al, 1942; Oldham et al, 1944; Daum
et al, 1949; Dick et al, 1958 and Ziporin et al, 1965).
The findings of Leevy et al, 1965b, are consistent
with the estimate of Takeda, 1947, suggesting that the
body stores are approximately 30 mgm.
If the body stores are small, it should be possible
to saturate them and provide the body's requirements by
giving an adequate intravenous dose of thiamine and so
prevent retention of the orally administered radioactive
thiamine.
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Approximately 0.05 mgm. of radioactive thiamine is
contained in the oral dose. An attempt was made to reduce
any exchange with the body stores by previous loading of
the patient and by the provision of additional flushing
doses each of 200 mgm. of non-radioactive thiamine to
dilute the absorbed radioactive thiamine. However, giving
additional flushing doses, or variation in time or route
of administration of the flushing dose, did not signifi¬
cantly increase the total 24 hour excretion of activity
nor alter the pattern of excretion, following 1.0 mgm. to
20.0 mgm. of oral thiamine., Previous studies have shown
that subjects on an ordinary diet with thiamine content of
about 1.5 mgm. usually excrete between 0.4 and 1.0 mgm. of
thiamine daily in the stool (Schultz, et al, 1938; Youmans
et al, 1940; Friedmann, et al, 1948; Alexander and Landwehr,
1946; Denko et al, 1946; Yano, 1958). Consequently, it
would seem that most of the 1.0 mgm. oral dose absorbed is
excreted during the first 24 hours, under the conditions of
the test. Further support of this conclusion is provided
by the observation that more than 90% of an administered
200 mgm. intravenous flushing dose was recovered in the
urine within the first 24 hours. There is little evidence
of re-excretion of thiamine into the intestine as observed
in rats by Gassmann and Ketz, 1961, under the conditions
of the test. The total excretion of thiamine in the bile
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as measured by Ochromonas danica in bile obtained from a
patient with T-tube drainage, was only 110 pgm. total in
24 hours after an intravenous dose and 70.4 pgrn. after
an oral dose of 15 mgm. of thiamine hydrochloride. (Baker
et al, 1968). Haugen (1961), showed that excessive
amounts of thiamine are rapidly excreted by the kidney
and in the present investigation there was no evidence
that at any time the kidneys were unable to excrete the
load presented to them.
In control subjects, the major period of absorption
was in the first two hours after the 1.0 mgm. oral dose
(Figure 8). This was also true at higher oral dose levels
although the period of absorption was prolonged (Figure
10). At all dose levels, the rate of appearance of radio¬
activity in the serum anticipated, by a very short interval
of time, the pattern of excretion seen in the urine. The
200 mgm. intravenous flushing dose appeared to distribute
itself throughout the total body water 30 minutes after
administration. The low serum levels obtained from orally
administered thiamine were explicable if the rate of
absorption and the rate of excretion of the total body
thiamine were taken into consideration. The distribution
of the orally administered thiamine seemed to be modified
by the presence of the flushing dose and appeared to be
mainly limited to the extracellular fluid. A straight line
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relationship was found to exist between the amount of
thiamine excreted after 1.0 mgm. oral dose together with
200 mgm. flushing dose (y) and log(log) time (x) which
could be described by the equation y= 0.5810 + 0.4247x.
Radioactivity has been detected in the serum within
the first three minutes in control subjects following
orally administered 35S-thiamine and small amounts have
been detected in the urine in the first five minutes in
some subjects. This suggests that thiamine is absorbed
high in the intestinal tract. Studies using the technique
of combined umbilical and hepatic vein catheterization,
demonstrated consistently that following an oral dose the
serum radioactivity first rises in the portal vein, then in
the hepatic vein and finally in the femoral artery. At all
times, the concentration of radioactivity is greater in the
portal vein than in the hepatic vein and lowest in the
femoral artery. These observations indicate that thiamine
is absorbed via the portal system rather than via the
lymphatics.
The amount of thiamine appearing in hepatic venous
blood depends upon its extraction ratio. Provision of a
large saturating dose of thiamine prevented significant
retention in both deficient and repleted subjects. Several
factors contribute to the observed portal-hepatic vein
thiamine gradient including tissue equilibration, arterial
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inflow, and extracellular distribution of the vitamin. As
previously stated, preliminary data indicate less than 1%
of a 15 mgm. dose of radioactive thiamine is recovered
from the bile over a 24 hour period. Absorption via the
portal system was previously suggested by Bean et al, 1951,
who sampled from an anastemotic abdominal vein and a peri¬
pheral vein in two cirrhotic patients. An evaluation of
the data was presented in the introduction. The work of
Middleton and Grice, 1964, in the rat indicates that the
site of maximum absorption is in the duodenum and upper
small intestine and this agrees with the findings of Polin
et al, 1964, in the chick.
The results of the test must be carefully interpreted
in patients with severe renal disease. When the creatinine
clearance is below 35 ml./min., both the rate of excretion
and the total amount excreted may be reduced. This is not
thought to be secondary to malabsorption of thiamine since
the peak radioactive value occurs in the serum between 1-2
hours. In patients with creatinine clearances greater than
35 ml./min. there nay still be some delay in the rate of
thiamine excretion, but this becomes less marked as the
renal disease becomes less severe. Because of the small
number of subjects, it was not possible to relate the
reduction in thiamine excretion to the region of the kidney
involved in the disease process.
Comment
Many of the quantitative tests used to measure
vitamin Bl absorption in man have been unsatisfactory
either because they were unable to measure thiamine and
its metabolites accurately or because unknown amounts of
absorbed thiamine were being incorporated into the body
stores or utilized in body metabolism erroneously suggest¬
ing reduced absorption. The limitations of methodology
made the interpretation of data extremely hazardous and no
reliable test to measure thiamine absorption has been
developed which can be used routinely. Evidence presented
here indicates that the use of 35S-thiamine hydrochloride
pith an appropriate flushing dose, provides a simple and
reliable method for measuring thiamine absorption in man.
CHAPTER II
THE INFLUENCE OF GASTRO-INTESTINAL DISEASE
ON THIAMINE ABSORPTION
Introduction
Disease of the small intestine may cause impaired
absorption of certain water-soluble vitamins. Patients
with primary malabsorptive disease (idiopathic steaterr-
hoea), for example, frequently fail to absorb folic acid
normally (Girdwood, 1953; Girdwood & Delamore, 1961;
Chanarin, et al., 1958; Cox, et al., 1958). Although
clinical evidence of deficiency of other water soluble
vitamins is rarely present, investigations using the
tryptophan loading test have suggested subclinical de¬
ficiency of pyridoxine in patients with tropical sprue
and primary malabsorptive disease (Kowlessar et al., 1961;
Sigler et al., 1962). Baker & Sobotka (1962) have shown
that patients with primary malabsorptive disease may have
subnormal levels of serum pyridoxine and Brain & Booth
(1964), using tritium-labelled pyridoxine, have demon¬
strated impaired absorption of pyridoxine in some of
these patients.
Girdwood (1956), using microbiological methods,
studied the absorption of water soluble vitamins in
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patients with primary malabsorpti.ve disease, but found
no evidence of malabsorption of thiamine, riboflavin or
pyridoxin© in 10 patients with impaired absorption of
folic acid. Except for this investigation, little has
been published on the absorption of thiamine in patients
with intestinal malabsorption.
Methods and subjects
Patients with primary raalabsorptive disease included 10
cases who had ,not been treated with a gluten free diet.
The diagnosis was established by jejunal biopsy and the
results of the following absorption tests - folic acid
absorption (Girdwood, 1953: Girdwood & Delamore, 1961),
vitamin 3-j^ absorption (Schilling, 1953), xylose absorp¬
tion (Fourman, 1943) and faecal fat excretion (Kramer et
al. , 1949). A sternal marrow was performed and serum
folate, formiminogluatmic acid (FIGLU), and vitamin B
levels were measured. All patients had a barium meal and
follow-through examinations. There were also 13 patients
who had been treated with a gluten free diet for periods
varying from 3 months to 5 years.
The other patients included 10 with gastroenterostomies
8 withpartial gastrectomies and 3 patients with pernicious
anaemia who had confirmed acid-fast achlorhydria in
response to a maximum histamine test meal and were un¬
treated at the time of investigation. Three patients had
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Crohn's disease and one who had had a sub-total proximal
gastrectomy with an end-to-side oesophago-gastric anasta-
mosis for an anaplastic carcinoma of the stomach 17 years
previously, but there was no postmortem evidence of a
recurrence when she died from a myocardi*al infraction
some months after completion of the studies. Two of the
patients with Crohn's disease had had a resection of the
terminal ileum and a right hemicolectomy.
Standard Test. Most of the patients studied in this
section were given the standard test of i.e. 1.0 mgm.
oral dose of 35S-thiamine hydrochloride together with
200 mgm. of non-radioactive thiamine intravenously.
Divided collections of 24 hour urines were made.
RESULTS
Primary Malabsorptive Disease. The excretion of eight
patients with primary malabsorptive disease given 300
mgm. intravenously 48 hours before the standard test was
26.7%(SEM + 5.11) which was significantly less than the
control group (t = 3.504; p<0.01). When the 300 mgm.
"loading" dose was omitted there was no decrease in the
recovery of urinary radioactivity 28.1% (SEM +• 4.75)
Tables 17; 18. The difference between these patients
and the controls was not due to a decreased ability to
excrete thiamine as a patient was able to excrete an
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Table 17. Thiamine absorption in patients with primary
malabsorptive disease
Standard test repeated in the same subject after giving 300 mgm.
thiamine intravenously 48 hours before the second test.
Subjects No. of subjects Before loading After loading
Untreated 8 28.1 ± 4.75 26.7 ± 5.11
Treated 13 36.9 ± 4.33 40.8 t 3,84
The results are expressed as the mean i SEM (n)
Loading was achieved as before (See Table 2)
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intravenous dose normally.
Rate of Urinary Excretion
The cumulative excretion of radioactivity in a
"loaded" untreated patient showed delay in excretion and
marked reduction in the total excreted 9.4% although
maximal excretion occurred within the first 6 hours. (Fig¬
ure 19) When this test was repeated in the same subject,
11.0% of the oral dose was recovered and the pattern of
excretion was identical.
Additional Flushing Pose3 given to three malabsorptive
patients during the 0-24 hour period and to two others
during the 24-48 hour period did not alter the pattern
of excretion or significantly increase the total radio¬
activity excreted; the details of one patient are shown
in Table 19.
In thirteen patients who had been treated with a
gluten free diet and replacement therapy, previous load¬
ing again had no effect on the excretion of radioactivity.
(Table 20). The previously "loaded" treated patients did
not differ from the control group (t=2.012; 0.5<p<0.01)
but differed significantly from the untreated patients
(t.=2 . 231; 0 . 02<p<0 .05) . Table 20
Miscellaneous Conditions
The standard oral test dose was given to three
FIGURE 19. Cumulative urinary excretion of radio¬
activity after 1.0 mgm. of 35S-thiamine hydro¬
chloride (THCL) orally and 200 mgm. non-radioactive
thiamine intravenously in a control subject and a
patient with primary malabsorptive disease.
7<>OralThiamine-S35Hci.excreted cnOLnO<-'1C)<-r'Ocr,OuiO 1iii
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Table 19, The effect of additional flushing doses in a patient
with untreated primary uialaosorptive disease
The patient was given 300 mgra. thiamine intravenously 48 hours
before each test.
Time Urinary radioactivity Time of additional Urinary radio-
hr after Standard Test 100 mguw i.v. flushing activity after
deses of thiamine additional flushing





12 - 24 6.3 5.0
25.2 29.3
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patients with Crohn's Disease (Table 21). The test in
patient No. 1 was performed three weeks prior to opera¬
tion during which 33.5 cm. of terminal ileum were
resected and found to have severe changes consistent with
a diagnosis of Crohn's Disease. Patient No. 2 had had
50 cm. of terminal ileum resected and a transverse colos¬
tomy performed and in patient No. 3, 17 cm. of jejunum had
been resected from a point about three feet from the
duodeno-jejunal flexure. In both of these patients, the
pathologist reported changes consistent with Crohn's dis¬
ease. The results of the test were normal in all three
patients.
Patients with untreated pernicious anaemia also
showed normal results (Table 22).
Gastric Surgery
The results in eight patients with gastroentero¬
stomies are shown in Figure 20 and Table 23. The rate of
absorption and thfe total urinary excretion of radioactiv¬
ity were normal (t = 0.395; p<0.5).
The absorption of thiamine following partial gas¬
trectomy was also studied in eight patients and the re¬
sults are presented in Table 24. The mean absorption was
70.6% + 4.8. When this was compared with the control
group using the student t-test, and was not found to be
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Table 21. Standard oral test in three patients with Crohn's
disease previously saturated with 300 mgia. of
thiamine intravenously
vit, B12 THIAMINE**





1. 4S F 14.4 44 6.1 190 Malabgo^gtion 35.2
2. 42. F 14.6 43 2.6 207 Equivocal 52.0
10.7%
3. 49 F 13.6 40 4,8 148 Malabsorption 60,5
5.09%
No. Age Sex Hb
gm/100ml
P.C.V. Serum Serum
% folate Vit, li12
ngsa/tal pgc/tnl
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Table 22. The standard oral test In three patients
with pernicious anaemia
No. Age Sex Hb P.C.V. Marrow Serura Acid THIAMINE"




I. 70 F 10.A 33 Mep. 1U5 Achlorhydria 32.8
2. F 7.3 22 Meg. 50 Achlorhydria 42.A
i A3 M 8.2 2A Meg. 75 Achlorhydria 53.0
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Table 24, Thiamine absorption In eight patients with partial
gastric refactions previously saturated with 300 agm,
of ncn~radioactive thiamine intraveneously






1,0 mgm. 5.0 fagra.
Date Operation
1. 79 M 13.0 40 49.5 43.3 Partial gast. i960
2. 56 V 13.2 42 52.9 48.3 Partial gast. 1959
3. 73 F 12.5 38 65,6 - Subtotal gas*-. 1949
4. 50 F 12.0 39 69.6 61.1 Partial gast. 1954
5. 45 M 11.9 39 71,6 - Partial gasc. 1943
6, 76 77 11.2 35 76.1 -
7. 66 M 14.0 46 81,4 - Partial gast. 1957
8. 69 M 13,6 47 98.8 «• Partial gast* 1953
70.6 50.9
9. 68 M 13.0 40 3.8 mm Partial gast. 1955
significantly different t=1.8228 p<0.1>0.05. One patient
with a partial gastrectomy excreted only 3.8% of the oral
dose. This patient had an abnormal villous pattern of the
intestinal mucosa. In some areas the villi were normal
in appearance but in others they were broad, interlacing
and even fused. The changes were not typical of mal¬
absorption and may have been associated with altered
gastric function but, since the findings were exceptional,
the patient was not included in the statistical evaluation.
He excreted 39% in the first 24 hours when the same dose
was given intravenously.
Patient number 3 had had a subtotal proximal gas¬
trectomy with an end-to-side oesophago-gastric anasto¬
mosis for an anaplastic carcenoma of the stomach 17 years
previously, but there was no postmortem evidence of a
recurrence when she died of a myocardinal infaction some
months after completion of the studies.
Influence of bacterial flora on thiamine absorption.
The influence of bacterial flora on thiamine absorp¬
tion was investigated using organisms which had been
obtained from the jejunal juice of patients with primary
malabsorptive disease and freeze dried. The organisms
were kindly donated by Dr. Dellipiani (Dellipiani and
Girdwood, 1964). The uptake of cyanocobalamine by the
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bacteria was tested and the findings were almost identical
to those obtained previously. Their ability to utilize
*>
both 35S-thiamine and tritiated H -folic acid was tested
by adding 477 nc. of folic acid or 49 nc. of 35S-thiamine.
The solution was sterilized at 15 lb. pressure for 10
minutes. One ml. of a sixteen hour culture of an organ¬
ism was added to an aliquot. Two standards of 10 ml. of
broth with added labelled vitamin but inoculated with one
ml. of sterile saline, were used as controls. After over¬
night incubation at 37°C the material was centrifuged at
3,000 revolutions per minute for 30 minutes and compared
with that in the uninoculated control samples. The
radioactivity in the supernatant was calculated using a
well-type scintillation counter or Pakard scintillation
counter. Measurement of radioactivity in the organisms
confirmed that it had been removed from the culture medium
and could not be washed off the organisms. The results
are shown in Table 25.
The rate of uptake of cyanocobalamine by two organ¬
isms shown to utilize vitamin B-^ was investigated by pre¬
paring 6X 10 ml. of broth containing 58 Cobalt-labelled
cyanocobalamine as above. Following incubation, a tube
was centrifuged after zero time, one hour, two hours, five
hours, twelve hours and twenty-four hours and the radio¬
activity in the supernatant measured. The results are
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Table 25. Uptake of labelled cyanocobalamine, folic acid,
and thiamine by organisms isolated from patients
with malabsorptive disease
% Uptake of Radioactivity
Organism Cyanocobalamine Folic Acid Thiamine
58Co H3 35S
0,38nc/ml. 47.7nc/ml. 49nc/ml.
1. Klebsiella (1) 88% 0% 0%
2. Klebsiella (2) 90% 0% 0%










shown in Figure 21.
Although four of the organisms removed over 85% of
the cyanocobalamine from the incubation medium, no uptake
of thiamine or folic acid could be demonstrated. In view
of the rapid absorption of thiamine suggesting that
absorption occurs primarily in the jejunum, the absence
of fsuacal flora from the jejunum in most patients as in
controls and the failure of the organisms isolated to
take up thiamine invitro, it seems unlikely that malab¬
sorption in primary malabsorptive disease is secondary to
utilization of the orally administered thiamine by bac¬
teria. This conclusion is in keeping with the previous
findings that little breakdown of thiamine appears to
occur in the lumen of the intestine.
DISCUSSION
Patients with untreated primary malabsorptiva dis¬
ease excreted significantly less radioactivity than the
control group (t= 3.504 p<0.01). The cumulative urinary
excretion showed delay and marked reduction in the total
excreted. These factors were uninfluenced by previous
loading with 300 mgm. of thiamine intravenously or by
additional flushing doses given during the 0-48 hour
period. Using these tests, I was able to exclude the
possibilities that the flushing dose was inadequate or
FIGURE 21. The rate of uptake of 58C. cyanocobala-
mine by organisms isolated from patients with mal-
absorptive disease.
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that absorption had occurred after the flushing dose had
been excreted. The difference between the patients with
malabsorption and the controls was not due to a decreased
ability to excrete thiamine as a patient was able to
excrete an intravenous dose normally.
At the time that this part of the work was being
carried out, the restrictions on the amount of 35S-
thiamine which could be given to each patient made it
necessary to test absorption at one dose level only. It
was decided to choose a physiological dose which would
be large enough to show that the subject was capable of
absorbing his minimum daily requirement during the 24
hours but which did not exceed the reserve capacity of
the intestine in the control subject. The minimum daily
requirement in the adult human has been estimated at
between 0.23 mgm/1000 cal and 0.66 mgm/1000 cal (Williams,
et al. , 1942; Oldham, et al., 1944 ; Daum, et al., 1949;
Dick, et^jal. , 1958 and Ziporin, et al. , 1965). The work of
Morrison & Campbell (1960) ; Friedemann, et al., (1948) and
Schultz, et al., (1938) suggests that little further
absorption occurs when the dose of thiamine exceeds 4-5
mgm. Therefore, 1.0 mgm. was chosen as a reasonable oral
dose.
The paired t-test showed no significant difference
between malabsorptive patients who had been previously
loaded and those who had not, either before, or after
treatment. It was also shown that the mean of the un¬
treated malabsorptive patients, with previous "loading"
was significantly less than the treated patients. How¬
ever, the mean of the treated malabsorptive patients, who
were not given 300 mgm. 4 8 hours before treatment, was low.
Consequently, further statistical tests were applied.
Seven of the eight differences in the untreated patients
were positive but the result of the Wilcoxen's sign test
(Spiegel, 1956) confirmed the t-test findings. Similarly,
in control subjects, previous "loading" did not signifi¬
cantly alter the result. Consequently, the average of the
result before and after "loading" was taken in each mal¬
absorptive patient and the resulting two groups compared
with the control group considered as twenty independent
observations. A one-way analysis of variance on these
three groups was found to be highly significant confirming
the difference between the untreated and control groups.
P [F + 5.21; d.f. (2,38)] - 0.99. The one-tailed t-test
applied to the average of the treated and untreated mal¬
absorptive patients, gave t= 1.8 with 19 d.f. and this was
significant at the five per cent level.
Although thiamine absorption primarily seems to occur
high in the gastro-intestinal tract, it is possible that,
in the patient with primary malabsorptive disease, more
absorption occurs in the ileum. However, most of the
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thiamine is absorbed during the first 4-5 hours even in
these patients and for bacteria to significantly reduce
the amount of thiamine available, they would need to be
present in sufficient numbers at a level where absorption
is occurring. None of the bacteria isolated from the
jejunum or the ileum of patients with primary malabsorp-
tive disease could be shown to utilize thiamine when
incubated invitro for 24 hours. The possibility that the
reduction in absorption is only apparent and that thiamine
is being produced, by abnormal bacteria, in quantities
adequate to give reduced absorption of the orally adminis¬
tered thiamine, is very doubtful. Thiamine deficiency can
be corrected by refected rat faeces (Mickelson, 1956), and
liver thiamine levels are higher in conventional than
germ-free chicks given a thiamine free diet (Luchey et al.,
1955). Nevertheless the nutritional importance of intes-
tinally synthesised thiamine must be questioned since the
thiamine sparing effect of antibiotics is negated by pre¬
vention of coprophagy (Marneesh et al., 1959, Barnes et al.,
1960). Since thiamine synthesised by micro-organisms
appears to exist in a macromolecular form that is not well
absorbed (Wosbmann and Knight, 1961), and since even free
thiamine is poorly absorbed from the caecum (Kwong ejt al. ,
1962).
Consequently, there is little evidence that abnormal
bacteria play a significant role in the malabsorption of
the patient with primary malabsorptive disease. It is
also true that thiamine deficiency per se cannot be the
cause of these patients failing to absorb thiamine since
intravenous thiamine did not improve absorption. Neither
was there any correlation between the ability of these
patients to absorb thiamine and other intestinal absorp¬
tion tests or with the severity of the changes shown by
jejunal biopsy. The results in these patients illustrate
again the variation in the ability of individual patients
to absorb different substances during the acute phase of
the disease.
Wang & Harris (1939) and Drummer & Markkanen (1960)
measured the daily urinary excretion of dietary thiamine
in achlorhydric subjects and found evidence of reduced
absorption. During the present investigation, four
patients with pernicious anaemia and three with histamine
fast achlorhydria following gastric surgery, were all
found to excrete normal amounts of radioactivity. If
absorption is grossly impaired, malabsorption may become
apparent when the test dose is small. A larger oral dose,
however, may result in a greater difference between
normals and patients or may demonstrate impairment which
was not obvious with the smaller dose as occurs with
xylose absorption. Consequently, the results in
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achlorhydria are not necessarily incompatible with the
observations of VJang & Karris (1939) and Brumner & Mark-
kanen (1960) although there nay be other factors pro¬
ducing depletion in their patients.
Three patients with Crohn's disease involving the
terminal ileum, and showing impaired absorption of vitamin
Bjl2 / excreted normal amounts of radioactivity after the
standard test for thiamine, suggesting that absorption of
vitabine in the human is mainly in the upper small
intestine.
In eight patients who had had gastro-enterostomias,
there was no alteration in either the rate of absorption
or in the total urinary excretion of radioactivity. Eight
patients with partial gastrectomies also failed to show
any significant difference from the control group. One
patient with a partial gastrectomy excreted only 3.8% of
the oral dose and was excluded from the statistical eval¬
uation. This patient had an abnormal villous pattern
which may have been associated with altered gastric func¬
tion. He excreted 89% in the first 24 hours when the
same dose was given intravenously. A patient who had
had a sub-total gastrectomy 17 years previously excreted
65.5%. The presence of a normally functioning stomach
does not appear to be essential for the absorption of
physiological amounts of thiamine.
CHAPTER III
STUDIES IN OLD AGE
Introduction
Evidence of thiamine deficiency has recently been
reported in elderly subjects by several workers. (Brin,
etal., 1964; Brin et al., 1965; Griffiths, et al., 1965).
Intestinal absorption has an important role in determining
the nutritional status but has not been extensively studied
in old age. This problem is of particular interest because
of reports of structural changes in the small intestine in
later life (Lascalea, 1959; Andrew, 1961; Suntzeff &
Argeletti, 1961) and the demonstration by Fry et al.,(1961)
of a reduced rate of cell production in the crypts of the
jejunum of mice.
There is evidence of impaired absorption of fat
(Becker, et al., 1950), amino acids (Wild, et al., 1953),
galactose (Meyer et al., 1943) and of certain vitamins -
vitamin A (Yiengst & Shock, 1949) and vitamin B^2 (Chow,
1954; Glass, et al., 1955). Although Chinn, et al. (1956)
found no significant difference in the rate or the extent
of protein digestion and absorption in old age and the
findings of impaired absorption of vitamin B^2 have not
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been confirmed by subsequent work (Swendseid, et al.,
1954; Chow, et al., 1956; Tauber, et al. , 1957; Hyams,
1964) .
Rajsky & Newman (1943) measured the urinary excre¬
tion of thiamine in twenty-two elderly subjects and found
that a larger dose was required to produce a constant out¬
put than in younger subjects. This may have resulted from
reduced absorption although there is evidence that suggests
thiamine requirement increases with age (Mills, 1948;
Oldham, 1962). The work of Draper (1958) in the rat
showed that the absorption of an oral dose of radiothiamine
decreased substantially beyond the age of 20 months. Kirk &
Chieffi (1951) measuring faecal thiamine in man, however,
found little change in percentage absorption with increasing
age at the dose level used.
Methods and Subjects Studied:
Method for the study of absorption of 35S~thiamine.
The radioactive material was diluted with non-radio¬
active thiamine so that each test dose contained 1.0 mgm.,
5.0 mgm. or 20.0 mgm. and 5^ic of radioactivity dissolved in
20 ml. of water. The test dose was given orally to sub¬
jects after an overnight fast and a parenteral injection
of 200 mgm. of non-radioactive thiamine was given immedi¬
ately before the oral dose. Urine collections were removed
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after 5 hours, 12 hours, 24 hours and 48 hours and counted
as previously described.
The effect of additional flushing doses in elderly subjects
Three subjects over the age of eighty were given 20.0 mgm.
of radioactive thiamine orally and 200 mgm. flushing dose.
The results were compared with those obtained when the
test was repeated in the same subject with additional 100
mgm. flushing doses given intravenously at 4 hours, 9
hours and 24 hours after the oral dose. Urine was col¬
lected at hourly intervals for the first four hours, then
at 12 hours, 24 hours, 36 hours and 48 hours. The details
of a 90 year old subject are shown in Table 26. The
results obtained in the other two subjects were 21.0%,
22.7% and 17.7%, 16.3%. These results are similar to
those obtained in younger patients and consequently the
200 mgm. flushing dose was subsequently used at all three
dose levels.
Subjects Studied.
Two groups of convalescent hospital in-patients who
were free from haematological, gastro-intestinal, endo¬
crine or malignant disease, were studied: Group 1 con¬
sisted of 24 subjects aged 76 - 90 years (mean 82.1 years).
Group II consisted of 21 younger subjects aged from 28-56
years (mean 48.9 years). Fifteen members of the older
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Table 26. Effect of additional flushing doses in a
ninety year old subject
tmmmmmmmmmmmmmmmmmammammmmmtwMmmmmmmmmmammmmmmmmmmBmmmtmmmmmmmmmmmmmmmmmmmammmmmmmmm
Time Urinary radioactivity* Time of additional Urinary radio-
HR after first test** 100 mgm« i.v. flush- acltivity






4-12 6.31 4 hr. 6.65
12 - 24 7.06 9 hr. 4.96
Total for 24 hr. 18.41 17.17
24 - 36 2,53
24 hr.
2.93
36 - 48 2.58 4.14
Total for 48 hr. 23.52 24.24
*Result expressed as percentage oral dose.
Subject given 20 mgm. radioactive thiamine orally.
**First test « 20.0 mgm. radioactive thiamine orally and 200 mgm.
non-radioactive flushing dose intravenously at the same time.
group received a test at each of the oral dose levels i.e.
1.0 mgm., 5.0 mgm., and 20.0 mgm. of thiamine. The order
in which the tests were performed was randomised. The
remaining nine were given one test only. Ethical reasons
prevented more than two tests being carried out on any
individual in the younger group. The dose to be. omitted
was again determined from random number tables (Documenta
Geigy, 1965).
RESULTS
The results obtained when subjects in both groups
were given tests at each of the three oral dose levels
are summarised in Tables 27, 28, and 29. In figures 22,
23, and 24 the percentage excretion of radioactivity of
both the younger and the older groups, at each dose level,
have been plotted against age. A regression analysis was
performed at each of the dose levels but no correlation
between age and the percentage excretion of radioactivity
could be demonstrated (At 1.0 mgm. oral dose/age t = +
0.002 (35 d.f.) p> 0.5; 5.0 mgm. t = + 0.687 (27 d.f.)
p=0.5; 20.0 mgm. t = + 0.673 (30 d.f.) p>0.50].
Rate of excretion of the flushing dose and orally adminis¬
tered thiamine in old age.
Attempts to assess the rate of thiamine absorption in
elderly subjects were often difficult to interpret because
of frequent renal impairment and retention of urine in the
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Table 27. Thiamine absorption in younger and older
groups at three oral dose levels
Oral dose radioactive Urinary Excretion of radioactivity





3.03 (21) 51.8 ± 2.97 (16)
2.14 (17) 40.8 ± 4.71 (12)
1.23 (18) 25.8 - 3.69 (14)
*The results are expressed as the mean - SKM (n). Urine was collected
for 48 hours.
Subjects were given 200 mgm. non-radioactive thiamine flushing dose
intravenously at the time of the oral dose.
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1 28 66.0 - 17.4
2 30 - 31.2 25.2
3 45 - 38.6 39.8
4 45 40.0 - 36.6
5 46 45.3 - 19.1
6 48 58.0 29.1 -
7 48 51.2 40.1 -
o 49 - 72,1 8.5
9 50 36.1 - 24.8
10 50 31,2 - 22.9
11 51 63.6 4MB 50.0
12 51 64.6 18.4 -
13 51 46.2 54.3 -
14 52 37.8 - 16.2
15 52 59.8 - 23.6
16 53 - 22.3 16.1
17 53 66.9 - 52.6
18 53 45.7 38.7 -
19 54 51.6 38.4 -
20 55 - 38.1 9.2
21 56 65,5 68.2 -
MEAN
i SEM







Results are expressed as % radioactive oral dose excreted.
Subjects were given 200 mgm. non-radioactive thiamine flushing
dose intravenously at the time of the oral dose.
Urine was collected for 48 hours.
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Table 29. Thiamine absorption in the older group at three oral dose levels
1.0 mg&ii. 5.0 ngs. 20.0 mgra.
Age Sex Oral Dose Oral Dose Oral Dose
76 M 42.6 32.0 18.0
77 F 62.9 52.5 28.5
78 F 62.6 41.3 17.4
80 F 38.8 43.9 20.8
80 F 60.0 32.5 22.4
81 F 53.1 25.9 21,0
82 F 39.5 38.7 25.5
82 p 55.1 23.6 27.9
82 M 49.0 36.5 22.6
83 F 41.2 26.0 14.9
84 M 45.2 26.0 16.5
84 kk 42.5 41.2 21.2
85 M 52,3 24.5 13.4
88 F 40,7 18.0 26.5
88 F 42.3 32.1 15.6
77 •% *fi - - 18,1
80 M 84.0 - «*•
80 M 34.1 - -
82 M 52.3 mm
82 F 67.2 mm -
83 F 53.0 * -
84 Ven. - 37.8 -
90 M - - 23.5
MEAN 53.1 33.4 21.2
X €*T?\4
Uiiil 3.03 2.14 1.23
Results are expressed as % radioactive oral dose excreted.
Subjects were given 200 ragm. non-radioactive thiamine flushing
dose intravenously at the time of the oral dose.
Urine was collected for 48 hours.
FIGURE 22. Excretion of 1.0 mgm. oral dose of














EXCRETION OF 1.0 MGM. ORAL DOSE 35S-THIAMINE
AT DIFFERENT AGES
FIGURE 23. Excretion of 5.0 mgm. oral dose of



















EXCRETION OF 5.0 MGM. ORAL DOSE 35S-THIAMINE
AT DIFFERENT AGES
FIGURE 24. Excretion of 20 mgra. oral dose of
35S-thiamine hydrochloride (THC1) at different
ages.
AGE (YEARS)
OP 20.0 mgni. oral dose 35S-THIAMINE
AT DIFFERENT AGES
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bladder after voiding. Four subjects were chosen who had
previously been catheterised but who retained good renal
function. The rate of excretion of 200 mgm. thiamine
flushing dose was studied by incorporating 35S-thiamine.
After one week, 1.0 mgm. of 35S-thiamine was given orally
together with a non-radioactive 200 mgm. flushing dose and
a divided urine again collected.
The results of one 83 year old man are shown together
with those of a young subject in Figure 25. The rate of
excretion of the flushing dose was not very much less than
in the younger subject but the rate of excretion of the
oral dose is significantly reduced. This may be due in
part to reduced renal function but it suggests that
absorption from the intestine may be slower although the
total amount absorbed will not be significantly different
from the younger subjects as previously shown.
DISCUSSION
The results agree with those of Kirk & Chieffi (1951).
They measured faecal thiamine using a chemical method
(Hennessy & Cerecedo, 1939; Friedmann & Kmieciak, 1943)
before, during, and after a 5.0 mqm. daily, oral supple¬
ment but found little change in thc.- percentage absorption
with increasing age. The minimum daily requirement of
thiamine for the young adult has been estimated at between
0.23 mgm/1000 cal and 0.66 mgm/1000 cal (as shown in the
FIGURE 25. Comparison of the cummulative urinary
excretion of a 35S~thiamine labelled 200 mgm.
flushing dose and a 1.0 mgm. standard oral test





discussion of Chapter I of this thesis) and the daily
allowance suggested by the National Research Council ig
1.3 mgm. per day. (National Research Council Publication,
1958) Evidence suggests that for the rat (Mills, 1948)
and for man (Oldham, 1962) this requirement may be in¬
creased in old age. However, both at a physiological
level and a very much larger doses, no difference has
been found between the two groups in this present study.
This is not to say that deficiency may not occur due to
inadequate intake of thiamine. Despite an apparently
adequate diet, the availability of nutrients at the cellu¬
lar level may vary widely between individuals due to lack
of appetite or poor dehtition. Food served in institu¬
tions may receive extra cooking to make the food tender
and readily digested and this may be responsible for
destruction of heat labile nutrients. The individuals
studied were chosen to exclude certain diseases and
nothing can be said about the absorption of thiamine in
these patients. Nor were any subjects studied who had
advanced protein malnutrition in which severe intestinal
atrophy. ^as keen observed (Passmore, 1947-1948; Gillman
and Gillman, 1951; Brock, 1961; Deo and Ramalingaswami;
1964). However, the findings do suggest that there is not
an inevitable decline with age in the ability of the intes¬
tine to absorb vitamin B-^ and that deficiency in most elderly
people need not arise provided that adequate amounts are
present in the diet.
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CHAPTER IV
STUDIES ON THE MECHANISM OF THIAMINE ABSORPTION IN MAN
Introduction
There is evidence suggesting that thiamine behaves dif¬
ferently to most other water soluable vitamins and that
there is a limit to the amount of thiamine that can be
absorbed from a single oral dose. Schultz et al., 1938,
state that in the human subject receiving 5.0 mgm. of thia¬
mine daily, almost all of an additional 5.0 mgm. oral dose
could be recovered from the faeces. Melnick et al., 1945,
found a break in the linear dose-response curve at an in¬
take of approximately 5.0 mgm. daily and Friedmann et al.,
1948, concluded that the maximum amount that could be
taken orally without resultant increase in faecal thiamine
was about 5.0 mgm. per day. These findings were supported
by Morrison and Campbell, 1960, who found little increase
in the amount of thiamine excreted in a 24 hour urine
occurred when an oral dose greater than 2.5 mgm. was given.
The evidence indicating an upper limit to the amount
that could be absorbed from a single dose suggests that a
saturable mechanism for thiamine absorption may exist in
the intestine. Work by Polin et al. , 1963a., using an invivo
technique in white Leghorn hens indicated that thiamine
absorption from an isolated duodenal loop conformed to
the Michaelis-Menten kinetics and that amprolium (an anti¬
metabolite of thiamine) competitively inhibited thiamine
absorption. Further work by the same authors Polin et al.,
1963b, in 3 - 5 week old chicks, however, suggested that
absorption occurred by diffusion. This is in contrast to
the findings of Magyar and Gabor, 1949, who found that
prior administration of thiamine reduced the amount of
thiamine that could be absorbed from an isolated intes¬
tinal loop and to those of Ventura et al., 1963, who showed
that comparatively greater absorption of small than large
doses of thiamine.
Thiamine absorption using invitro techniques was
investigated in rats by Turner and Hughes, 1962, and by
Spencer and Bow, 1964. Neither author was able to demon¬
strate passage of thiamine against a concentration gradient
and no reduction in the presence of inhibitors has noted.
Ventura and Rindi, 1965, suggested that the two previous
workers had chosen an initial concentration which was too
high and repeated the experiments using initial concentra¬
tions of 0.21jx M/l. on both sides of the sac. They con¬
cluded that net transport of thiamine against a concentra¬
tion gradient occurred, that metabolic inhibitors, thiamine
analogue pyrithiamine and the decreased incubation temper¬
ature inhibited transport suggesting that thiamine was
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absorbed by active transport. Sharma and Quastel, 1965,
suggested that thiamine transfer into the brain cell of
the rat was a carrier mediated mechanism dependent upon
sodium pump.
The possibility that thiamine was phosphorylated
during its intestinal absorption was suggested by Linneweh
and Muller, 1940; and Magyar and Gabor, 1949. Rindi and
Ventura, 1966, found a significant increase in phosphory¬
lated thiamine in the intestinal wall two hours after the
introduction of thiamine hydrochloride but the relationship
between thiamine phosphorylation and thiamine absorption
was not established. More recently, Gassmann and Sandner,
1967, proposed that thiamine was phosphorylated in the
lumen of the intestine by pancreatic secretions prior to
absorption but the experiments left many unanswered ques¬
tions .
The results obtained by different workers provide
conflicting views of the mechanism of thiamine absorption.
In man, workers seem to agree that there appears to be a
limit to the amount of thiamine that can be absorbed from
a single oral dose but the reasons for this have not been
identified. The methods used to measure thiamine often
fail to identify its many metabolites. The reduction in
thiamine excretion secondary to storage and utilization
is not known nor was the possibility of thiamine break¬
down in the intestine investigated.
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In the investigations which follow, the relationship
between the oral dose given and the amount of thiamine
absorbed in control subjects was studied in an attempt to
clarify the factors operative in normal man. The effect
of massive intestinal resection on thiamine absorption
will also be presented.
RESULTS
Maximum 12 hour urinary excretion of radioactivity foJLlow-
ing a single oral dose of 35S-thiamine hydrochloride
Fifty-six normal subjects were given oral doses of
thiamine hydrochloride ranging from 1.0 mgm. to 20.0 mgm.
containing 10 pc. of 35S-thiamine together with 200 mgm.
intravenous flushing dose. Each subject was given a test
at three oral dose levels, the order in which tne tests
were performed being randomized. Seven other control
subjects were given oral doses of 50 mgm. or 200 mgm. of
radioactive thiamine together with a flushing dose.
Urine was collected in 0 to 5, 5 to 12, 12 to 24, 24 to
48 and 48 to 72 hour aliquots.
The results obtained are summarised in Table 30.
These results are shown plotted in Fig. 26 where the
abscissae represent reciprocals of the oral dose of
thiamine (d) and the ordinates reciprocals of the total
amount of the oral dose excreted in 72 hours (S).
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Table 30. Seventy-two hour urinary excretion of radioactive
thiamine by normal subjects after varying oral
doses of 35S-thiamine hydrochloride*
Oral dose Urinary excretion
radioactive Radioactivity
thiamine Per Cant Mean weight** Number of
(mgm.) oral dose* (mgm.) subjects
1.0 51.0 +mm 2.07 0.51 ± 0.02 45
2.0 46.7 + 4.47 0.93
+
0.09 10





m$ 3.76 1.47 + 0.12 10





6.63 4.33 ± 0.66 10
20.0 23.8
+











♦Subjects were given 200 mgra. of thiamine hydrochloride intravenously
at the time of the oral dose.
+
**Results are expressed as the mean - SEM. Urine was collected for 72 hours.
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FIGURE 26. The linear relationship between the recip¬
rocal of the dose of radioactive thiamine (THC1) given
orally and the reciprocal of the cumulative 72 hour
urinary radioactivity. Each point represents a mean
value + one S.E. ; 200 ragm. of non-radioactive thiamine
was given intravenously with each oral dose. The inset












Each point has been shown + one standard deviation. The
points fall on a straight line suggesting that the relation¬
ship between the oral dose of thiamine administered (d) and
the total amount of the oral dose excreted (S) may be
represented empirically by an equation of the Michaeli.s and
Meritan (1913) type, namely
S = V.d
K + d (1)
where,
V = the maximum attainable 72 hour excretion of orally
administered thiamine following a single dose.
K = the dose of oral thiamine which gives 72 hour
excretion equal to V/2.
This can be transformed to the linear relationship between
reciprocals, as in Fig. 25.
LL-) m £ • ll) . I
\S ' V V d / + V (2)
Regression analysis using the weighted-least-squares
procedure (Wilkinson, 1961) was performed to test the appli¬
cability of this formula to the data and obtain V max and the
Michaelis constant K. d. was treated as the independent
variable and V as a normal randomly distributed variable with
the expected value
Vmax.d
E (V/d) "K + d (3)
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and variance
Var (V/d) = <r- 2 (4)
Calculations of K and V with their standard errors were
based on fitting a bilinear regression of V on the corres¬
ponding values of the provisionally fitted Michaelis-Menten
function and its first derivative (Wilkinson, 19G1). Results
obtained with doses of 50 ngm. and 100 mgm. were not used in
the calculations because of the small number of subjects
studied with this dosage. The techniques employed do not
permit a direct estimate of the initial rate of absorption
but it has been shown by Fisher and Parsons (1953) that if
the relationship between the concentration at any moment and
the rate of absorption at that moment is of the form of equ.(1)/
then the relationship between the initial concentration and
the average rate of absorption will be expected to be also of
the form of oqu.(1). As previously discussed in Chapter I,
the available evidence suggests that the net passage of
thiamine from the intestine is unidirectional and little
parenterally administered thiamine appears .in the faeces.
When the data was plotted according to the Linweaver-
Burk method (1934) a straight line relationship was obtained
between administered and excreted radioactive thiamine (Vmax
8.3:K= 12.5). The calculated maximum amount of thiamine
(Vmax) absorbed following receipt of a single oral dose (K)
required to produce half maximum absorption was 12.0 + 2.4
mgm. (range 3.5 - 13.1; confidence probability 0.95). and the
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size of the oral dose (K) required to produce half maximum
absorption was 12.0 + 2.4 ragin. These values + two standard
errors have been indicated on the inset of Fig. 26.
The results must be interpreted with caution. It should
be pointed out that the V max. presented is analogous to but
not identical with the maximum calculated rate at time zero.
A better estimate might have been obtained by using the
thiamine excreted during the first 30 minutes after the oral
dose but it was decided not to do this because the errors
introduced by gastric emptying and passage along the intestine.
Similarly, Michaelis-Menten theory is based on changes in
concentration of the substrata. It has been assumed that the
variation in the amount of fluid present in the intestine
with time and between individuals is small but this has not
been measured. Since the measurement of thiamine absorption
is indirect, it is also possible that the rate limiting factor
may not be in the intestinal mucosa but in the transport
system of the blood, in the tissues or imposed by renal
excretion. These possibilities and additional considerations
are discussed later. The present estimate of the amount of
thiamine that can be absorbed requires refinement by increasing
the sample size.
Influence of intestinal resection on thiamine absorption.
If thiamine is absorbed by a mechanism which can be satur¬
ated, then a man who has had an intestinal resection may show
a reduction in the maximum amount of thiamine which can be
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absorbed from a single oral dose. It may also be possible
to obtain some information on the site of thiamine absorption
in man. The case history is described below of a man who
was admitted to hospital with a mesenteric thrombosis which
required resection of all of his intestine except for four
inches of jejunum and the distal half of the colon. Following
recovery from the operation, his ability to absorb thiamine
was tested at three different dose levels, 1.0 mgm., 5.0 mgm.,
and 20 mgm. after vitamin repletion. The results are presented
in Figures 27, 28 and 29, where they are compared with results
in control subjects. In Figure 27, the results found in a
FIGURE 27. The linear relationship between the recip¬
rocal of the dose of radioactive thiamine (THC1) given
orally and the reciprocal of the cummulative 72 hour
urinary radioactivity in normal subjects, a mal¬





malnourished alcoholic are shown here for comparison
although this subject will not be discussed until the
next chapter.
Clinical Presentation
In 1954 at the age of 60 years, this white male
patient underwent an extensive subtotal gastric resection
(Billroth I) in which more than 75% of the proximal por¬
tion of the stomach was removed. In June 1966, he was
admitted to hospital in mild congestive heart failure
with atrial fibrillation which was subsequently controlled
by digoxin and a low sodium diet. A Schilling test at
that time showed 7.3% recovery. In May 1967, he was re¬
admitted with signs of intestinal obstruction. Laparotomy
revealed a mesenteric thrombosis and all of the intestine
except for the proximal four inches of the jejunum and the
distal half of the colon were removed, an end-to-end
anaste#mosis being performed between the jejunum and
transverse colon. He recovered from this operation but
developed diarrhoea, passing five or six bulky stools
daily with inability to maintain his weight. One month
postoperatively, he was transferred to the metabolic unit
for study. Clinical examination revealed evidence of weight
loss, glossitis with lateral margin atrophy of the filliform
papillae. Hyperkeratosis on his arms and legs and decreased
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vibration sense at the ankles. He had controlled atrial
fibrillation and his weight was 45 kilograms. He was
given a 50 gram fat, 120 gram protein and 1000 ragm.
sodium diet which helped to control his diarrhoea and
to maintain his weight.
Two weeks later, the following investigations were
done.
Haematological findings. The patient had been given 1000
ml. of whole blood during the operation. On transfer his
haemoglobin was 10.9 gm. per cent, red cells were 2,810,000
per c.m.m., P.C.V. 38 per cent, white cells were 4,500 per
c.m.m. Stained blood films revealed moderate hypochromiar
he had a serum iron 22, total iron binding capacity 210
and a bone marrow was normoblastic but showed no free iron.
His anaemia failed to respond to oral ferrous sulphate but
did respond to intramuscular iron. Serum B^2 was 89
ml. and serum folate was 2.3 mjig/ml.
Biochemical findings. Serum Na+ was 136 meq/1., K+ 3.9
raeq/1, Ca ++ 8.5 meq^l. Alkaline phosphatase was 10 King-
Armstrong units. Total serum proteins were 5.5 gm. (albumin
41.1%, o<, 8.9%, 6<t16.9%, ^ 9.7% and 23.4%.) Serum
creatinine was 0.8 mg %, protein bound iodine 6.2 mgm. per
100 ml. and total fasting serum lipids 160 mgm. per 100 ml.
The prothrombin time was initially 5 second prolonged but
promptly connected with parenteral administration of
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Vitamin K-^.
Hepatic and Intestinal Anatomy. A liver biopsy revealed
mild fatty metamorphosis. The architectural pattern was
well preserved, there was no fibrosis seen, the findings
being consistent with malnutrition. The barium follow
through showed a normal mucosal pattern (Figure 30) and
a section taken from the proximal and of the resected
intestine confirmed the presence of a normal villus
pattern. (Figure 31)
Absorption Tests. Glucose absorption was abnormal; the
fasting level was 67 mg% but the blood glucose failed to
rise above 97 mg% following an oral dose of 50 gm. of
glucose. Xylose absorption showed 0.5 gm. excreted in
5 hours following 25 gm. oral dose. The absorption of
vitamin (Schilling Test) one year prior to his intes¬
tinal resection was 7.3% but were repeated after the oper¬
ation was zero without intrinsic factor following a test
dose of 1 jig and 1.3% when given with 50 mgm. of hog
intrinsic factor.
The results obtained indicate considerable reduction
in the serum levels of radioactivity; the rate of rise in
cumulative urinary excretion and in the total amount
excreted in the 72 hour period at all three dose levels.
(Figures 28 and 29) In Figure 27 the reciprocals of the
oral doses given are plotted against the reciprocals of
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FIGURE 23. Comparison of the patterns of radioactivity
seen in a normal subject and a patient with an intes¬
tinal resection after 1.0 mgm. of 35S-thiamine hydro¬
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FIGURE 29. Cununulative urinary excretion of radio¬
activity after 1.0 mgm. oral 35S-thiamine hydrochlor¬
ide (THC1) and 200 mgm. flushing dose in a normal
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FIGURE 30. Barium meal and follow through examination
showing the extent of the intestinal resection and the
normal pattern of the remaining jejunal mucosa.
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FIGURE 31. Section from jejunum of patient showing
a normal villous pattern.
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the total 72 hour excretion of thiamine. The results
obtained in controls is shown for comparison. It will be
seen that the points again fall on a straight line. The
maximum amount of thiamine which can be absorbed from a
single dose by this patient (V-max), 1.1 mgm. as compared
with 4.5 mgm. for the controls. It is of interest that
the patient excreted only 5.0% of the 20 mgm. oral dose
in the 72 hours i.e. 1.0 mgm. which approximates the pre¬
dicted excretion from a saturating dose. This is true
also of the 20 mgm. dose given to control subjects (Figure
26) .
DISCUSSION
The results agree with the findings of Melnick et al.,
1945; Friedmann et al., 1948 and Morrison and Campbell,
1960, that there appears to be an upper limit to the amount
of thiamine that can be absorbed from a single oral dose.
It was found that on average 4.5 mgm. of thiamine was the
maximum amount which appeared in the urine following any
saturating dose over the range tested.
Many workers have studied thiamine absorption but the
findings are difficult to correlate due to the variations
introduced by the different experimental animals used, the
lack of uniformity in the size of dose studied, and the
different methods used to measure the amount of absorption
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that has occurred. Melnick et al., (1945) stated that in
normal subjects receiving nutritionally adequate diets,
the urinary excretion of water-soluable vitamins, or
their derivatives, was directly proportional to the quan¬
tity consumed. The upper limits for thiamine tested by
Melnick et_al. was 7.5 mgm. and inspection of their data
reveals that a break in the linear dose-response relation¬
ship occurred at an intake of about 5.0 mgm. per day.
Friedmann et^jal. , 1948, concluded that the intestinal
absorption of thiamine and hence its excretion, was ex¬
tremely limited. The maximum amount which could be taken
orally without a resultant increase of faecal thiamine was
about 5.0 mgm. per day. Previously, Schultz et al. (1938)
had reported that, in subjects receiving 5.0 mgm. of
thiamine daily, almost all of an additional dose of 5.0
mgm. thiamine was recovered in the faeces.
Morrison and Campbell (1960) investigated the absorp¬
tion of thiamine in six normal male subjects. The subjects
were given of 1.0 mgm. to 20 mgm. of thiamine after break¬
fast. The excretion of thiamine was measured in divided
urine samples by the thiochrome method until it returned to
control levels. The results are shown in Table 31. It was
found that the excretion of thiamine, expressed as a per¬
centage of the oral dose, decreased markedly with doses
greater than 2.5 mgm. Increasing the dose from 2.5 mgm.
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Table 31. Effect of size of dose on urinary excretion of thiamine
Dose Thiamine, mean
net excretion
ragtn mgm % of dose
1 0.276 27.6 ± 4.3*
2.5 0.525 21.0 t 3.6
5.0 0.435 8.7 ± 0.7
10 0.640 6.4 « 0.6
20 0.740 3.7 ± 1.1
♦Standard error of the mean.
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to 20 mgm. increased the amount of thiamine excreted by
only 0.2 mgm. The results obtained by Japanese workers
who measured the 24hr. urinary excretion of thiamine, fol¬
lowing oral doses of 2,6,10, 25, 50 and 100 mgm. of thia¬
mine daily are summarised in Table 32. It was concluded
that the pattern of intestinal absorption conforms to the
view that an upper limit exists to the amount of thiamine
absorbed from a single oral dose.
Watanabe, 1951, showed that doses of thiamine up to
400 pgm. were readily absorbed by the rat based on urinary
output. Middleton and Grice, 1964, gave 20 pgm. of 35S-
thiamine by stomach tube to 200-250 gm. Wistar rats and
analysed the radioactivity remaining in the intestine at
varying times after the oral dose. It was found that 88%
of the dose had been absorbed after six hours and that 20%
was retained in the liver. In a second series of experi¬
ments, the same oral dose was given and the amount of
radioactivity excreted in the urine and faeces in the sub¬
sequent 48 hours was measured. It was found that approx¬
imately 34.3% of the dose was excreted in the urine and
10.8% in the faeces - presumably 42.9% being retained in
the body. These findings are in good agreement with earlier
findings of Middleton and Morrison, 1962, who found that
29.1% + 5.8% of a 20 pgm. dose was excreted in the urine in
a four day period with 5.5 + 3.3% in the faeces.
Table32.Relationshipb tweenthamou tforaladmini tra ion andtheurinaryexcretionithcaseofrdi aryth mi e Timeaft rAdministration







































Da Silva and Ivy, 1961, gave 40 mgm. of thiamine
orally for six days to 20 kgm. dogs and measured the daily
urinary and fefitcal excretion of thiamine by the fluor-
rnetric method of Burch et al. , 1952. The average daily
feacal excretion of thiamine in excess of that in the con¬
trol period was approximately 46% of the dose with 16%
appearing in the urine. Presumably, 38% was either re¬
tained in the body, destroyed or present as undetected
metabolites in urine or faeces. This suggests that approx¬
imately 21.7 mgm. of thiamine were absorbed daily. These
workers also found that approximately 30% of a 10 mgm. of
thiamine was absorbed from the Thiry fistula of the jejunum
or ileum in one hour, no significant difference being found
between the two portions of the intestine. It was possible
to recover all of the thiamine introduced into the loop and
there was no evidence of thiamine destruction when incu¬
bated invitro with fluid obtained from washing the loop.
Therefore, although workers had varied in their choice of
animal, in their choice of size and number of different
dose levels investigated and in their methodology, it was
apparent that there was an upper limit to the amount of
thiamine that could be absorbed from a single dose and in
man this was between 8-14 mgm. The intestinal capacity to
absorb the vitamin had not been studied in the rat but
increased faecal excretion occurred in a 100 gm. rat when
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0.12 mgm. were fed. On a body weight basis, therefore,
maximum absorption would be greater than 1.2 mgm./kgm.
for the rat, approximately 1.1 mgm./kgm. for the dog and
0.07 mgm./kgm. for man. This suggested that a species
difference existed and that the intestinal capacity to
absorb thiamine, on a body-weight basis, was greater in
the rat than in the dog, and greater in the dog than in
man.
It is of interest that plotting the reciprocals of
the means for the different groups provides a relationship
between, the dose given and the total oral thiamine excre¬
tion, which can be represented by an equation of the
Michaelis & Menten type (1913). It may be that in the
fasting state, the oral dose given is directly related to
the initial concentration in the lumen of the intestine
and that the total excretion, under test conditions, repre¬
sents the average rate of absorption. Conformity to
Michaelis-Henton kinetics, however, does not necessarily
indicate that an enzymic process, with a rate-limiting
step, is involved. As stated by Fisher and Parsons, 1953,
if absorption on to some carrier complex were the rate
limiting process, the same kinetics would obtain. But, it
does show that the results are not explainable on the
basis of simple diffusion alone.
Since the measurement of thiamine absorption is
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indirect, it is possible that the rate limiting factor may
not be in the intestinal mucosa but in the transport
system of the blood, in the tissues or imposed by renal
excretion. Thiamine may be transported in the blood in
the phosphorylated form coupled to a protein carrier (Baker
et__al. , 1967) and it is possible that this mechanism could
become saturated. However, the total body store of thia¬
mine in man has been estimated to be 30 mgm. and repeated
flushing doses of 100 mgm. each have not altered the
pattern of excretion or the total amount of radioactivity
excreted. For the same reasons, it is unlikely that tissue
binding or utilization could introduce a rate limiting step
especially as 90% of the radioactivity, during the period
of maximum absorption, is excreted in the form of thiamine.
At high blood levels, thiamine is actively secreted by the
kidney tubules (Haugen, 1961) . Excretion of intravenous
thiamine is maximal during the first half hour whereas the
peak serum level of thiamine and the maximal period of
excretion of the oral dose is at about 90 minutes by which
time the rate of excretion is far below its initial levels.
At no time during the period of absorption of the oral
dose is there evidence that the excretory mechanism is
being saturated. An estimate of the amount of thiamine
absorbed has been made by measuring the total excretion
of radioactivity during the 72 hour period following the
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oral dose but, most of the activity is excreted in the
first 12 hours.
It is possible to show that absorption of thiamine
from the intestine occurs during the period when the con¬
centration of thiamine in the portal vein, due to the
flushing dose, is greater than the concentration in the
intestine. However, the form in which a large intravenous
dose would be transported has not been determined and it
is not known whether this could represent evidence of
passage of thiamine against a concentration gradient.
Consequently, the most likely explanation for the upper
limit to thiamine absorption would seem to be that thia¬
mine is absorbed by active transport, fascilitated dif¬
fusion, or a non-active process involving a rate limiting
step, for example, absorption on to a cell surface.
The mechanism of absorption was investigated by
Polin et al., 1963a, in White Leghorn hens. A duodenal
loop 1-13 cm. long was prepared so as to exclude the bile
ducts and the pancreatic tissue. Following an injection
of 2.0 or 4.1 jjmoles of thiamine into the loop, the
incision was closed and the animal returned to the cage
for 30 minutes before sacrifice. The loop was then re¬
moved, and both the intestine and its contents homogenized.
Following extraction, an aliquot of the supernantant was
analysed for thiamine. The experiments were also repeated
in the presence of 28 pnoles of amprolium. The relation¬
ship between the amount of thiamine absorbed and the dose
given conformed to the Michaelis-Menton relationship
graphically represented by the Lineweaver-Burk plot. (Line-
weaver and Burk, 1934). The results in the presence of
amprolium suggested that competition for absorption existed
between amprolium and thiamine. The authors concluded that
amprolium and thiamine are absorbed from the duodenum by an
active carrier mechanism rather than by simple diffusion.
Further work by the same authors (Polin et al., 1963b),
confirmed their earlier findings and excluded the possi¬
bility that a chemical complex of thiamine and amprolium
within the intestine could account for the interference
effect. A further publication by the same authors three
months later, however, showed that thiamine absorption
from the ligated duodenal loop in 3-5 week old chicks pro¬
duced a dose absorption curve which was linear passing
through the origin. (Polin et^ al. , 1964) . From 250 jigm.
to 50 mgm. in one ml. volume were introduced into the loop
and the relationship between the amount absorbed and the
amount injected into the loop was described by the equa¬
tion y = 0.09 + 0.73x mgm. until the dose exceeded 10 mgm.
Higher doses produced a curving phase interpreted as rep¬
resenting thiamine toxicity or osmotic imbalance.
Turner and Hughes, 1962, investigated the absorption
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of thiamine using the everted sac technique of Wilson and
Wiseman, 1954, and the loop technique of Fisher and Parsons,
1949, in both rats and hamsters. Thiamine was estimated by
the fluorimetric method of Bessey et al^, 1949. Varying
concentrations from 20 pmole/1. to 60 mole/1, were added
to the mucosal side in the first experiments, and the
course of vitamin absorption was determined by measuring
the initial and final concentrations of vitamins in the
mucosal solution but little change in the concentration
was detected. Similarly, when the initial concentration
on the mucosal side was compared to the accumulation on the
serosal side, it was found that the final concentration of
thiamine on the serosal side was always lower than the
mucosal concentration and the system never reached equilib¬
rium. Consequently, passage against a concentration gradi¬
ent was not demonstrated. In experiments in which the
initial concentration was the same on both the mucosal and
serosal sides (20pmoles/l.), there was a loss of thiamine
from the serosal side and an increase in the vitamin con¬
tent of the tissue. No movement of thiamine from seroasal
to mucosal side was detected but jejunal sacs incubated
without added vitamins showed loss of thiamine from the
tissue preferentially to the mucosal side 36+ 5.3 x 10
moles/cm./hour.
The effect of cytotoxic inhibitors such as cyanide was
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to increase the amount of vitamin passing across the
mucosa. The authors concluded that in the absence of
evidence of movement against a concentration gradient and
failure to demonstrate reduced absorption in the presence
of inhibitors, it was thought that thiamine absorption
obeyed Fick's Law of diffusion (Hober, 1945). One compli¬
cating factor was to evaluate the influence of water move¬
ments. The concentration differences resulting from the
absorption of solute could be masked by movements of water.
Also, a linear relationship between the rate and concen¬
tration gradient, while consistent with diffusion, does
not exclude absorption by enzymic mechanisms. A similar
result could be obtained in a transport process mediated
by enzymes provided the substrate concentration is well
below the Km. It is also possible that the authors used
too high a dose and were already dealing with a saturated
system in which comparatively small changes in concentra¬
tion were not detected. Other problems in interpretation
result because of doubt about the biological integrity of
the preparations at the end of the incubation period.
They were shown to respire actively for the whole period
and to be able to oxidise glucose but histological sections
were described as "although showing no gross damage, Never¬
theless , were not in as good condition as those reproduced
by Fisher and Parsons, 1949." There were no tests to
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demonstrate inhibition of the passage of thiosulphate nor
is it certain that all of the thiamine was in a form measured
by the assay method.
Spencer and Bow, 1964, also investigated thiamine
absorption in hamster intestine using 35S~thiamine hydro¬
chloride. Their report contained no evidence of viability
or evidence that the preparation was not damaged and water
movements were not investigated. Their conclusions agreed
with the findings of Turner and Hughes, 1962, for they
were unable to demonstrate movement against a concentra¬
tion gradient and suggested the passage of thiamine occurred
from serosal to mucosal side.
Other workers also failed to find any evidence for
active absorption of thiamine in the rat invivo, at least
when relatively high doses of the vitamin were used.
(Stockholm et al., 1941). Watanabe, 1951, has reported
that young rats absorb doses of 120, 240, or 400 jigm. of
unlabelled thiamine with about the same efficiency, indi¬
cating that there is no threshold value within this range.
Draper, 1958, showed no impairment of radiothiamine absorp¬
tion in weanling rats fed on synthetic thiamine deficient
basal diet supplemented with 50 pgm./gm. of thiamine hydro¬
chloride although the experiments were carried out after a
24 hour fast and the animals were under light ether anaes¬
thesia. These findings are in contrast, however, to those
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of Magyar and Gabor, 1949, who reported that absorption
of thiamine from an isolated loop of intestine was reduced
by prior administration of large doses of thiamine or
other B-vitamins; to those of Ventura et al., 1963, who
showed comparatively greater absorption of small than of
high doses of thiamine, and to Polin et ab. , 1963a~b; who
employing intestinal loops of chicks, suggested that thia¬
mine uptake may be an active process superimposed on some
passive absorption. Active transport of thiamine has been
shown to occur in other tissues of the body. Sharma and
Quastel, 1965, using rat brain cortex slices in Krebs-
Ringer phosphate medium containing glucose and labelled
thiamine at an initial concentration of 0.2 jimole, 0.6
^imole and 1.0 pinole, concluded that thiamine transfer
into the brain cell was by a carrier mediated mechanism
depending upon the operation of the sodium pump. They
also found, however, that at high external concentrations
of thiamine, simple diffusion of thiamine into the tissues
caused the concentration ratio of total labelled thiamine
(tissue:medium) to become approximately unity. It has
also been shown that the transport of thiamine into the
bacterium, Lactobacillus fermenti, is dependent upon an
external source of energy and that this can be utilized
in the form of ATP (Neujahr, 1963).
Ventura and Rindi, 1965, noted that with several
substrates, for example, basic amino acids (Hagihira et
al. , 1961), pyrimidines (Schanker and Tocco, 1960) ,
d-xylose (Csaky and Lassen, 1964), the demonstration of
an uphill intestinal transport could be achieved only
using very low initial concentrations and applied this
principle to the study of thiamine transport in vitro.
Everted sacs (8 cm. long) from the upper small intestine
of rats (Wister strain 100-120 gm. body weight), prepared
according to Wiseman, 1961, were incubated with an initial
concentration of 0.21 ^mole/1, on both sides of the sac.
Thiamine was determined by a micro modification of the
thiochrome method. (Ass. Vitamin Chemists, 1951). A net
transport of thiamine against a concentration gradient was
demonstrated, the serosal concentration of the vitamin
increasing up to 2.1 times the initial one. The effects
of metabolic inhibitors and decreased incubation tempera¬
ture depressed the serosal accumulation of thiamine sup¬
porting the concept of an active transport mechanism. The
structural thiamine analogue, pyrithiamine, significantly
inhibited the transport of thiamine against a concentra¬
tion gradient. Since pyrithiamine is a potent inhibitor
of the thiamine phosphorylase from the rat intestine
(Cerecedo et al♦, 1954), it was suggested that phosphory¬
lation might be the basic mechanism of the intestinal
uphill transport of thiamine. It is interesting to note
that in several experiments in which the initial concen¬
tration of thiamine was 21 or 2.1 pmole/1. , no evidence
of an uphill transport was found, thus confirming the
results of Turner and Hughes, 1962. These results should
probably be accepted with reservations since when working
with an initial concentrations of 0.21 pinole./I. , non¬
specific binding to tissues has been shown to occur, but
the authors have demonstrated a concentration gradient.
One wonders about the accuracy of the thiochrome method
in this range of concentration and the unexplained reason
why the serosal surface alone was rinsed with 0.01 N
hydrochloric acid.
The possibility that thiamine is phosphorylated
during its intestinal absorption has been suggested by
some authors (Linneweh and Muller, 1940) although denied
by others (Stockholm et al., 1941). Several experiments
invitro (Tauber, 1938; Cerecedo et al, 1954) have demon¬
strated that intestinal tissue is able to phosphorylate
thiamine. However, the relationship between thiamine
phosphorylation and intestinal absorption has never been
clearly defined although Machida, 1955, found thiamine
phosphates in the wall of the isolated intestinal tract
of the rat after incubation with thiamine. This question
was re-examined by Rindi et al., 1966. They studied the
absorption of thiamine hydrochloride and thiamine-propyl
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disulphide (TPS), a thiamine derivative rapidly absorbed
and transformed into thiamine by the intestinal mucosa.
(Ventura et _al. , 1963b; Takenouchi and Aso, 1963) using
a modification of the Cori technique (Ventura et al. ,
1963a; Ventura et al., 1963b) on the small intestine
insitu. The rats were sacrificed two hours after intro¬
duction of the compound into the intestine, the thiamine
being determined by the thicchrome method (Ass. Vitamin
Chemists, 1951) with modification by Mickelsen et _sl. ,
1945, and the thiamine-propyl disulphide (TDS) being
determined by the method of Ventura et a1. , 1966. These
authors found that a significant increase in phosphory-
lated thiamine (Thiamine disulphide) occurred in the
intestinal wall two hours after the introduction of equiv¬
alent amounts of thiamine hydrochloride or TPS.
The experiments of Rindi and Ventura, 1966, have not
established the relationship between thiamine phosphory¬
lation and thiamine absorption. The accumulation of
thiamine phosphate during absorption cannot be taken as
evidence for its participation in transport as many cells
increase the concentration of intermediates of metabolism
upon the addition of utilizable thiamine. In 1933,
Wilbrandt and Last, proposed that sugars were phosphory-
lated at the cell membrane as part of a transport mechan¬
ism. Many workers found accumulation of sugar phosphates
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in the intestinal epithelium during sugar absorption (Lunds-
gaard, 1933; Laszt and Sullmann, 1933; Nagasawa, 1957;
Naito, 1914 and Papadopoulos and Roe, 1957).
This evidence was supported by the inhibition of glu¬
cose absorption by iodoacetate and phlorizin, believed to
be a specific inhibitor of phosphorylation reactions.
However, as the years passed, evidence accumulated that
cast doubt on the validity of the theory. Some of the
most convincing evidence against the theory came from
accumulated data on the specificity of sugar transport
(Wilson, 1962), and the work of Landau and Wilson, 1959.
In these studies, radioactive galactose was used to label
the glucose-6-phosphate pool within the tissue and the
proportion of transported glucose passing through the pool
was estimated by the radioactivity of the transported
glucose recovered on the serosal side of the intestinal
segments. These experiments indicated that less than 10%
of the transported glucose could have passed through the
pool. More recently, Crane et al., 1961, have suggested
a direct coupling of the sodium transport system to that
for sugars.
Gassmann and Sandner, 1967, presented evidence that
phosphroylation of thiamine occurred in the lumen of
the intestine and that extracts of pancreatic tissue
were able to phosphorylate thiamine invitro. Ligation
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of the pancreatic duct was associated with a decrease in
thiamine absorption. The explanation of the results were
open to other interpretations. Phosphorylation of sub¬
stances in the intestine occur near to the brush boarder
so that the constant traumaur and shedding of cells into
the lumen could explain the phosphorylated thiamine in
the intestinal tract. The demonstration of the ability
of pancreatic tissue to phosphorylate thiamine does not
necessarily mean that it plays an important role and
ligation of the pancreatic duct must alter lymphatic
drainage and the nature of the intestinal contents. The
experiments might have been more convincing had the pan¬
creatic juice been given orally together with thiamine
after duct ligation to show that the absorption defect
was corrected.
The mechanism of thiamine absorption has been inves¬
tigated by many workers using a variety of techniques in
different animal species. The results obtained have
often been inconclusive and at times contradictory. There
is no agreement on whether active transport or passive
diffusion is involved in the absorption of thiamine from
the intestine and what part, if any, phosphorylation plays
in the process. It is not known whether significant
breakdown of thiamine occurs in the intestine or what part
re-excretion into intestine plays at blood levels obtained
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following normal dietary intake.
Comment
The results presented in this chapter suggest that in
man thiamine hydrochloride absorption is rate limited. As
shown previously there is little evidence of significant
entero-hepatic circulation, breakdown of thiamine or re-
excretion into the intestine. The requirement for a
special mechanism of absorption, perhaps requiring recep¬
tor sites, makes the system vulnerable in the presence of
malnutrition or states interfering with the production of
substances concerned with the transport process.
CHAPTER VI
PATTERNS OF 35S-THIAMINE HYDROCHLORIDE ABSORPTION
IN THE MALNOURISHED ALCOHOLIC
Introduction
If a specialized mechanism was responsible for thia¬
mine hydrochloride absorption, then it seemed possible
that malnutrition or reduced synthesis of proteins second¬
ary to liver injury might be associated with thiamine
malabsorption. This possibility was further supported by
the known high incidence of thiamine deficiency among
alcoholic subjects and consequently I decided to investi¬
gate the possibility further.
Thiamine deficiency syndromes in the malnourished
alcoholic have been attributed to an inadequate intake
(Leevy, 1967) or defective utilization of this vitamin
(Fennelly et al., 1967; Leevy and Baker, 1968). It has
been assumed that malabsorption may also produce thiamine
depletion because of occasional inability to achieve
normal circulating levels of this vitamin by oral therapy
(Leevy et__al. , 1965). As shown in Chapter II, patients
with idiopathic steatorrhea characteristically exhibit
decreased absorption of 35S-thiamine which returns to
normal following treatment with a gluten-free diet. My
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preliminary work suggested that alcoholics often exhibit
a market reduction in intestinal absorption of radioiso¬
topic thiamine hydrochloride, attributable to ethanol
toxicity, nutritional deficiency, or both (Thomson et al.,
1968). The influence of malnutrition was subsequently
confirmed by Tomasulo et al., 1968, using the test which
I have described here and published (Thomson, 1966). The
present studies were undertaken to (a) determine the
effect, of ethanol and nutritional deficiency on absorption
kinetics; and (b) evaluate the influence of various thera¬
peutic regimens on thiamine absorption in malnourished
alcoholics.
Methods and Subjects Studies
Twelve alcoholics without malnutrition or evidence of
hepatic disease, and 17 malnourished alcoholics with
biopsy evidence of fatty liver or cirrhosis were selected
for study. None of the patients had clinical evidence of
intestinal, cardiac, or renal disease. Hepatic status
was evaluated in alcoholic patients by the serum bilirubin
(Molloy et_al-> 1937) serum glutamic pyruvic transaminase
(Wroblewski and La Due, 1956) indocyanine green (ICG)
clearance (Leevy et al, 1967) , and liver biopsy before and
after treatment. Estimated hetapic blood flow was deter¬
mined by the method of Leevy et al., 1962. Intestinal
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function was investigated by stool examination, upper
gastrointestinal x-rays, and jejunal biopsy in selected
patients. Nutritional status was evaluated by studies of
circulating levels of vitamins, serum protein electro¬
phoresis, serum cholesterol (Bloor and Knudson, 1966),
and serum magnesium (Hansen and Freier, 1967). Vitamins
and E were measured chemically. Thiamine, riboflavin,
nicotinic acid, folic acid, vitamin B-^, vitamin Bg,
biotin, and pantothenic acid were assayed by protozoologic
techniques (Baker and Frank, 1969).
The 35S-thiamine, specific activity 356 mc/gm. was
radiocnemically pure when tested in the following chroma¬
tographic system: N-propanol/water/IM acetate buffer
pH 5.0 (70:20:10) and pyridine/acetic acid/water (20:2:80).
Labelled thiamine was diluted with non-radioactive thiamine
hydrochloride so that each test dose contained from 1.0
mgm. or 5.0 mgm. of thiamine hydrochloride and 10 pc of
radioactivity dissolved in 20 ml of water. After an over¬
night fast, a parenteral injection of 200 mgm. of non¬
radioactive thiamine hydrochloride was given immediately,
after which the radioactive material was given orally.
Arterial blood was collected via an indwelling catheter
at 0, 3, 6, 10, 20, 30, 40, 60, 90, 120, 150, and 180
minutes. Urine was collected hourly for the first 5 hours
and then after 12, 24, 48, and 72 hours. Blood and urine
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radioactivity was determined in a Packard Tricarb scintil¬
lation counter as previously described.
Ethanol administration
Twelve healthy subjects were given ethanol, either
orally or intravenously, to investigate the influence of
ethanol on the absorption of 35S~thiamine hydrochloride.
Thiamine absorption patterns were compared with and without
ethanol in the blood and intestines by tests conducted one
week apart with their order randomized. Studies were ob¬
tained under conditions of hepatic vein catheterization in
2 patients to see if ethanol altered the route of absorp¬
tion; in these instances ethanol produced no significant
increase in estimated hepatic blood flow. Nine subjects
were given 180 ml of 79.39 g/100 ml of alcohol diluted 1:3
with water and administered in 6 doses at 2 hour intervals
after an overnight fast. Three subjects received intra¬
venous ethanol (1.5 gm/kgm body weight in a 20% solution)
infused at a constant rate for 1 hour after an overnight
fast. Blood was obtained at hourly intervals during and
immediately following the administration of ethanol for
measurement of serum ethanol and lactate. Five mg»w.of
35S-thiamine hydrochloride together with a 200 mgm. non¬
radioactive flushing dose of thiamine hydrochloride was
given by tube at the time of the last dose of oral ethanol
or immediately after the ethanol infusion was stopped.
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Absorption in malnourished alcoholics
Thiamine hydrochloride absorption was studied in 12
alcoholic patients with biopsy evidence of fatty liver with¬
out clinical or laboratory evidence of steatorrhea. Each
patient had clinical stigmata attributed to vitamin defici¬
ency including glossitis in 8 and peripheral neuropathy in
7. Serum protein electrophoreses were abnormal in each of
the patients. A significant reduction in circulating levels
of folic acid was present in 8, vitamin E in 7, vitamin Bg
in 5, thiamine in 4, vitamin B12 and pantothenic acid in 2,
and biotin in 1 patient. Blood sugar, BUN, hematocrit, and
serum magnesium were normal. Intestinal biopsies and gastro¬
intestinal series were normal. Each of the patients had
abnormal ICG clearance, 85% an increase in serum glutamic
pyruvic transaminase, and 50% an elevated serum bilirubin.
Absorption studies were conducted within 24 hours of
admission and repeated following the administration of 100
mgm. or thiamine hydrochloride and therapeutic quantities
of vitamin C and the B-complex administered parenterally
for 3 to 6 days. Absorption studies, nutritional evalua¬
tion, and liver biopsies were repeated following a 6 to 8
week period of a high carbohydrate (370 gm), high protein
(120 gm.) diet, vitamin supplements (thiamine hydrochloride
10 mgm., riboflavin 10 mgm., niacinamind 80 mgm., pyrid-
oxine hydrochloride 20 mgm., D-panthenol 20 mgm., d -biotin
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0.2 mgm., ascorbic acid 100 mgm., folic acid 5.0 mgm., and
vitamin 100 ugm. intramuscularly daily), and a 10 day
course of Oxandrolone (120 mgm. daily) to facilitate mobil¬
ization of liver fat. Three patients in this group had
absorption studies utilizing hepatic vein catheterization
before and after treatment.
RESULTS
Effects of ethanol
A 70% reduction in expected serum radioactivity, and a
52% decrease in expected urinary radioactivity (Figure 32)
was noted in 3 of 9 subjects in whom ethanol was given
orally, and 1 of 3 in whom it was given parenterally. Prior
to the receipt of the ethanol, the mean serum radioactivity
at 1 1/2 hours after administration of 35S-t.hiamine was
10,567 + 1,230 c/100 min/ml; after ethanol it was 3,927 +
1,014 c/100 min/ml. The mean 72 hour urinary thiamine
excretion of these patients was 56.5 + 5.9% of the admin¬
istered dose; after ethanol administration, the mean urinary
excretion was 27.2 + 5.1%. One subject retested after a
4 month period showed similar reduction in 35S-thiamirie
absorption following the administration of ethanol. Hepatic
vein catheterization showed that the route of thiamine ab¬
sorption remained the same with reduced uptake of the vitamin.
(Figure 33).
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FIGURE 32. The radioactivity in the serum and urine
after administration of 5.0 mgm. of radioactive
thiamine. (THCl) orally to 3 normal subjects with and
without prior administration of ethanol (1.5 gm per
kilo); 200 mgm. of non-radioactive thiamine was given




FIGURE 33. The radioactivity in the hepatic vein
and femoral artery after administration of 5.0 mgm.
of radioactive thiamine (THCl) orally to a normal
subject with and without prior administration of
ethanol (1.5 gni per kilo); 200 mgm. of non-radio¬
active thiamine was given intravenously along with
the radioactive thiamine.
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Serum levels of radioactivity following oral adminis¬
tration of 35S-thiamine in alcoholics with fatty liver or
cirrhosis were from 30 to 98% less than the lower level
established for normal subjects. Portal and hepatic
venous levels were reduced to the same extent. Pooled 72
hour urine specimens contained only 13.9 + 3.03% of the
orally administered radioactivity compared with 35.3 +
2.16% in control subjects (Table 33). Serum and urinary
radioactivity was not altered by parenteral administration
of thiamine hydrochloride, therapeutic quantities of C and
B-complex vitamins, or a 10 day course of Oxandrolone.
Repeat studies following a 6 to 8 week period of a nutri¬
tious diet and vitamin supplements revealed increase of
serum and urinary radioactivity to those of controls
(Figure 34). Combined umbilical and hepatic vein catheter¬
ization demonstrated a block of absorption at the intes¬
tinal level which was corrected with prolonged receipt of
a nutritious-vitamin supplemented diet (Figure 35).
DISCUSSION
The demonstration that thiamine absorption obeys
Michaelis-Menten kinetics makes it possible to ascertain
the mechanism whereby various factors interfere with its
intestinal transport. As shown previously, a marked de¬
crease in Vraax occurred in the patient with intestinal
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FIGURE 34. The radioactivity in the serum and urine
after administration of 5.0 mgm. of radioactive
thiamine orally to malnourished alcoholic subjects
before and after treatment; 200 mgm. of non-radio¬
active thiamine was given intravenously along with























































FIGURE 35. The radioactivity in the portal vein,
hepatic vein, and femoral artery before treatment
in a malnourished alcoholic following 5.0 mgm. of
radioactive thiamine orally. Hepatic vein and





resection, attributed to a reduction in the total number
of receptor sites. The identical reduction in Vmax noted
in malnourished alcoholics is interpreted as evidence
that receptor sites are damaged by prolonged receipt of
ethanol, nutritional deficiency, or a combination of these
factors. Time lapses required for restoration of normal
thiamine absorption are attributable to need for repair or
regeneration of mucosal cells with adequate receptor sites.
The calculated Vmax of 4.5 was found in normal subjects.
Reduction of thiamine absorption following parenteral
or oral ethanol provides an explanation for the occurrence
of thiamine deficiency syndromes in alcoholics despite
ingestion of food containing minimum requirements of this
vitamin. This finding makes it desirable to have alco¬
holics ingest thiamine at a time when ethanol is not in
body fluids or tissues to insure absorption of this vita¬
min. Further studies are desirable to pinpoint the
mechanism of altered absorption observed following receipt
of ethanol. Recent studies suggest direct toxic effects
on the gastrointestinal mucosa may be responsible since
ethanol in amounts given in our studies will reduce elab¬
oration of gastric and hydrochloric acid and temporarily
suppress cell replication (22).
Comment
The unpredictability of thiamine hydrochloride absorption
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in the sick and injured has made it desirable to evaluate
the therapeutic usefulness of other thiamine moieties
such as thiamine propyl disulphide (23), whose absorption
is not rate-limited. Thiamine in this form is readily
available for tissue use and rapidly corrects symptoms of
depletion (25). It thus appears that this or another
modification of thiamine which is readily absorbed should
replace the hydrochloride moiety for oral therapy in the
malnourished alcoholic.
CHAPTER VI
OBSERVATIONS ON THE ABSORPTION AND UTILIZATION
OF THIAMINE PROPYL DISULPHIDE
Introduction
Chemical and laboratory evidence of thiamine deficiency
often occurs in the alcoholic despite intake of established
daily minimal requirements of this vitamin (Thomson, Baker
and Leevy, 1968). This could result from failure to absorb
thiamine hydrochloride which is usually employed in food
or multivitamin supplements. My investigations into the
kinetics of 35S-thiamine hydrochloride transport indicate
that its absorption is rate-limited, and that either
ethanol or dietary deficiency may markedly reduce its intes¬
tinal absorption. The reduced absorption in malnourished
alcoholics was subsequently confirmed by workers at Johns
Hopkins University (Tomasulo, Kater and Iber, 1968) using
the test developed earlier in this thesis and published
(Thomson, 1966) . Japanese workers have found it is possible
to achieve higher circulating thiamine levels with thiamine
propyl disulpnide (Figure 36) than thiamine hydrochloride
(Nose and Iwashima, 1965) . If ethanol and malnutrition does
not interfere with its absorption, it would be desirable to
use thiamine propyl disulphide in food or multivitamin
supplements to prevent and treat thiamine depletion. The
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FIGURE 36. Structural formulae of thiamine hydro¬
chloride (THC1) and thiamine propyl disulphide (TPD).
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present studies were undertaken to (a) compare the route
and kinetics of absorption of thiamine propyl disulphide
and thiamine hydrochloride in alcoholic subjects with and
without malnutrition; and (b) determine the effectiveness
of oral thiamine propyl disulphide in correcting clinical
and laboratory evidence of thiamine depletion.
Methods and subjects studied
Studies were conducted in 10 healthy volunteers, 20
alcoholics without stigmata of liver disease or nutritional
deficiency, and 35 alcoholics with hepatomegaly with or
without neurological abnormalities. All subjects were male
with an age range between 31 and 45 years. Laboratory
studies included a hematocrit, white blood cell count,
blood sugar, blood urea, urinalysis, and serology for
syphilis. The alcoholic subjects had an evaluation of
hepatic status including a liver biopsy, studies of indo-
cyanine green clearance (Leevy et al., 1967) serum protein
electrophoresis, and serum bilirubin. Blood was obtained
to measure circulating levels of vitamins A (Carr-Price,
1926), E (Quaife et al., 1949), and C (Schwartz and
Williams, 1955) by chemical techniques; and assay of thia¬
mine riboflavin, niacin, folic acid, vitamin B, vitamin
D12' ' an<^ pantothenic acid, using protozoologic
methods (Baker and Frank, 1969). Patients with neurologic
signs had a spinal tap with measurement of cerebrospinal
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fluid, pyruvate, and lactate. (Friedmann and Haugen, 1943;
Olson, 1962).
Healthy volunteers and alcoholics without liver disease
had no clinical or laboratory abnormalities. Clinical
stigmata of nutritional deficiency were present in each of
the alcoholics with hepatomegaly. Eighteen had glossitis,
10 peripheral neuropathy, 5 skin hyperkeratosis, and 6
clasic features of V7ernicke's encephalopathy including
ocular palsy, confabulation, ataxia, and peripheral neuro¬
pathy. None had ascites, jaundice, hepatic coma, or
bleeding oesophageal varices. Liver biopsies revealed
fatty metamorphosis from 2 plus to 4 plus in 30, and
moderately advanced Laennec's cirrhosis in 5 of the pa¬
tients. Abnormalities of serum protein electrophoresis
and indocyanine green removal (Leevy et al., 1967) were
present in each of the patients with histological abnormal¬
ities. A serum folic acid of less than 4.0 m/igm. per ml. was
present in 25, a serum B6 of less than 28 mjigm. per ml. in 15,
blood thiamine of less than 20 mjigm. per ml. in 13, and blood
nicotinic acid of less than 2.5 jagm. per ml. in 5 patients.
Comparisons were made of blood and urinary levels of
thiamine after receipt of 20 mgm. or 50 mgm. or thiamine
propyl disulphide or thiamine hydrochloride given per os
after an overnight fast. Subjects were given the other
form of thiamine one week later. Ten ml. of blood was
drawn from the antecubital vein before thiamine
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administration and 1/2, 1, 2, 4, and 24 hours afterwards.
Urine was collected for 24 hours before and after the test
dose. Ochromonas danlca was used to measure thiamine
activity in blood and urine (Baker and Frank, 1969).
Protozoological measurement of thiamine activity in blood
and urine was measured by the specific and highly sensitive
method of Baker et al. (1964) using O. danica. Measurement
of metabolically active forms of thiamine in blood and
urine following oral administration of equivalent doses of
thiamine propyl disulphide or thiamine hydrochloride
allowed a direct quantitative comparison to be made of the
therapeutically available compounds.
Culture media and conditions of growth. Maintenance and
basal media for Ochromonas danics are given in Tables 34
and 35. The basal medium is made up in double strength
(twice the amount shown in Table 35.) The organism is
grown under constant illumination provided by three 40-
watt 'warm-white' fluorescent lights placed at approx¬
imately 1.0 m. from the culture. Cultures were maintained
by transfering one drop weekly to new maintenance medium
contained in 10 ml. screw-capped tubes.
Assay procedure. 2.5 ml. of double strength basal medium
is distributed in 25 ml. borosilicate micro-Fernbach flasks
provided with glass caps. The solution to be assayed is
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Table 34. Maintenance Medium for 0. Danica*
Constituent Amount
Trypticase** (nigra*) 200
Yeast autolysate***(mgm.) . 200
Sucrose (mgm.). . 1,000
"It 20 Liver"*®** (rage.) lu
Glycerol (w/v) (mgm*) *•«•• ....... 500
Distilled water to (ml.). ................ 100
*pH adjusted to 5,0 (KOH or I^SO^),
**Baltimore Biologic Laboratories, Baltimore, Maryland.
***Albimi Laboratories, Brooklyn, New York*
****Nutritional Biochemical* Co., Cleveland, Ohio.
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Table 35, Basal Medium for 0, Danica in Thiamine Assay*
Constituent Amount
Nitrilotriacetic acid** (mgta.) 20
KH_P0, (mgm,) 30l 4
3MgC0j—Mg (Qii) ("basic MgCOs") (tugui* ) » 40
CaCX>3 (mgm.) 5
Metals mix*** (mgm.) 1
NH^Cl (mgm.) a,*..*..**.,.*..,...... 30
MgS04-7H20 (mgm.) * 100
Biotin (mgm.), *0*001
L-Glutamic acid (mgnt.) 300
L-Histidine HC1-H20 (mgm.) . * . 40
L-Arginine HC1 (mgm.) •*••*••*•■••••*•*• 40
Glucose (mgm.) • *.•,«»».•..•*.•*,.•, .1,000
Distilled water**** (mi.), 100
*pH adjusted to 5.0 (KOH) after boiling,
**Kastman Organic Chemicals, Rochester, New York.
***l'roviaes the following! (I) Fe, 0,1 mgm. (as Fe-(NK^)2(S04)2-6H20);
(2) Zn, 0,05 mgm. (as ZnS04-7H20); (3) Mn, 0.025 mgm. (as MnS04~H20);
(4) Cu, 0,004 mgm, (as CuS04*-5H9Q) j (5) Co, 0,005 mgm. (as CoSO/j-^H-jO) ;
(o) B, 0.005 mgm. (as H3BO3); (7) Ho, p.0G25 mgiu. (as (^^K^)gHo^024"•
4il2u); and (8) V, 0.G005 mgm. (as Na^VO^-lOlI^O). J
****As indicated in text, this medium was prepared in double strength. It
can be made in quadruple strength without precipitation.
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added, and the volume is brought to 5 ml. with distilled
water. The flasks are then autoclaved for thirty minutes
at 118° to 121° C. 2 ml. of a five day maintenance culture
diluted with 10 ml. of distilled water is used for innocu-
lation; one drop of this solution added to each flask.
Incubation is at room temperature for three to five days.
Growth is expressed in optical density units measured with
a Welch Densichron equipped with a red-sensitive probe.
Standard solution. A concentrated standard solution of
thiamine hydrochloride (1.0 mgm. per ml.) is prepared in
distilled water. From this solution, dilutions are made
with distilled water so that a standard curve is obtained
containing 0.1, 0.3, 1, 3, 10, 30, and 100 mygm. of
thiamine per ml. of final medium. A blank of single
strength medium is included to estimate carry-over.
Thiamine solutions and basal media are stored at 4° C
with a few drops of volatile preservative.
Preparation of blood samples. Each ml. of citrated blood
is diluted with 2 ml. of 0.5 mgm. of transaconitic acid in
100 ml. of distilled water with potassium hydroxide added
to pH 4.5. This solution is autoclaved for thirty minutes
at 118° to 121° C. The debris is centrifuged off 0.5,
1.0 and 1.5 ml. of supernatant is added to individual
flasks containing 2.5 ml. of double strength basal medium.
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The volume is then brought t.o 5 ml. with distilled water.
The flasks are then autoclaved for thirty minutes, cooled,
inoculated and incubated as described.
Preparation of urine samples. An aliquot of the twenty-
four hour urine specimen is diluted 1:5 with buffer and
autoclaved for thirty minutes; it is then further diluted
1:10 with distilled water to dilute toxic components. The
urine, now diluted 1:50 is assayed as is blood, centrifuged
if necessary.
Other circulating vitamin levels. Vitamins were assayed
in serum or whole blood using the Carr-Price, 1957, for
vitamin A, a modification of the method of Schwarts and
Williams, 1955, for vitamin C and vitamin E by a modifica¬
tion of the method of Quaife et__al. , 1949. The B-complex
vitamins were assayed in serum or whole blood by proto-
zoologic techniques using Ochromonas danica for biotin,
Tetrahymena pyriformis for riboflavin, nicotinic acid,
pantothenic acid and the vitamin B6-complex, Ochromonas
malhamensis for vitamin an^ Lactobacillus casei for
folic acid (3aker and Sobotka, 1962).
Route of absorption. The route of absorption of the two
forms of thiamine was compared in 4 of the patients with
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cirrhosis using combined umbilical and hepatic vein cathet¬
erization. The blood thiamine was within normal limits at
the time of the procedure. Each subject was given 50 mgm.
of thiamine hydrochloride or thiamine propyl disulphide
through a Rehfuss tube. Hepatic blood flow was evaluated
using the Fick principle with indocyanine green (Leevy et
al., 1962) as the indicator. Arterial, portal venous, and
hepatic venous blood were obtained at 10-minute intervals
for thiamine levels.
Absorption in malnourished alcoholics. The influence of
hepatic and nutritional abnormalities on intestinal
absorption of thiamine hydrochloride and thiamine propyl
disulphide was investigated in 10 malnourished alcoholics
with fatty liver. Subjects were given 50 mgm. of thiamine
hydrochloride or thiamine propyl disulphide, the order
being randomized. Subjects were then treated with a
nutritious vitamin-supplemented diet for 6 to 8 weeks at
which time repeat biopsies were normal and clinical evi¬
dence of nutritional deficiency had disappeared. An
absorption test using the same form of thiamine as given
initially was repeated.
Assessment of therapeutic value of thiamine propyl disul¬
phide. The normal spinal fluid thiamine level was estab¬
lished in 35 normal subjects receiving spinal anaesthesia
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for minor operations. The clinical effectiveness of thia¬
mine propyl disulphide was evaluated in 6 patients hospital¬
ized because of Wernicke's encephalopathy. Five healthy
subjects served as controls. A comparison was made of the
ability of thiamine hydrochloride, thiamine pyrophosphate
and thiamine propyl disulphide to correct abducens palsy,
confabulation, ataxia, peripheral neuropathy, blood and
spinal fluid thiamine defects and elevated serum and spinal
fluid pyruvate. The controls and patients with Wernicke's
encephalopathy were randomly given 50 mgm. thiamine hydro¬
chloride, thiamine pyrophosphate and thiamine propyl
disulphide orally, in a single dose, followed by 50 mgm.
of thiamine propyl disulphide, if there was no response to
initial therapy.
RESULTS
Healthy volunteers and alcoholics without evidence of
disease had a mean blood thiamine of 40.7 + 1.9 mjugm. per
ml. Patterns of absorption were identical in these groups.
Oral administration of 50 mgm. of thiamine propyl disul¬
phide produced a peak blood thiamine of 1000 mpgm. per ml.
within 15 to 30 minutes, while 50 mgm. of thiamine hydro¬
chloride caused a maximum blood thiamine of 150 mpgm. per
ml. within 1 to 2 hours in the portal vein. A mean of
8.22 + 1.16 mgm. of thiamine was excreted over a 24 hour
period after receipt of thiamine propyl disulphide as
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compared with a mean of 1.36 + 0.42 mgm. following thia¬
mine hydrochloride (Figure 37). The increase in thiamine
first appeared in portal venous blood, secondly, in the
hepatic venous blood, and finally, in the femoral arterial
blood after either thiamine hydrochloride or thiamine
propyl disulphide (Figures 38, 39). Urinary excretion of
thiamine during a 24 hour period increased in a linear
fashion from 1.86 + 0.05 mgm. to 7.8 +1.3 with adminis¬
tration of 10 to 50 mgm. of thiamine propyl disulphide.
Urinary thiamine showed an increase of only 0.22 + 0.03
mgm. to 1.42 + 0.25 mgm. after 10 to 50 mgm. of thiamine
hydrochloride (Figure 40).
Malnourished alcoholics with fatty liver exhibited
an 80 per cent decrease in absorption of thiamine hydro¬
chloride over control values. There was a marked increase
in arterial blood thiamine of 200 + mpgm. per ml. 1 hour
after thiamine propyl disulphide, and an increase of only
9.2 + 3.0 mjigm. per ml. 1 hour after thiamine hydrochloride
(Figure 41). Mobilization of liver fat and improvement of
nutrition was followed by restoration of normal patterns
of intestinal absorption.
Spinal fluid thiamine was 30.5 + 5.4 mpgm. per ml. in
normal subjects. Spinal fluid and blood pyruvate were
0.95 mgm. per cent and 0.76 mgm. per cent, respectively in
normal subjects. Administration of 50 mgm. of thiamine
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FIGURE 37. Blood thiamine levels and urinary excretion
of thiamine following administration of 50 mgm. of


















FIGURE 38. Blood thiamine levels in portal vein,
hepatic vein, and femoral artery following 50 mgm.
of thiamine propyl disulphide (TPD).
218
MIN UTES
FIGURE 39. Blood thiamine levels in portal vein
hepatic vein and femoral artery following 50 mgm




FIGURE 40. Relationships between the amount of oral
administration of thiamine hydrochloride (THC1) or





FIGURE 41. Increase in blood thiamine and urinary
excretion of thiamine in malnourished alcoholic
patients given 50 mgm. of thiamine hydrochloride




hydrochloride produced negligible change in cerebral spinal
fluid thiamine in deficient subjects, whereas, a 2 to 30-
fold increase was noted when thiamine propyl disulphide
was given (Figure 42). Transfer of thiamine into the
cerebral spinal fluid was rate-limited, requiring 5 to 6
hours for significant increase. The 6 patients with
vJernicke's encephalopathy had a mean blood thiamine of
6.4 + 0.98 mjigm. per ml. a mean spinal fluid thiamine of
3.2 + 1.2 mjigm. per ni. a mean blood pyruvate of 3.11 +
0.86 mgm. per 100 ml., and a mean spinal fluid pyruvate of
2.20 + 0.28 mgm. per 100 ml. Oral thiamine hydrochloride
and thiamine pyrophosphate did not produce a significant
change in blood or spinal fluid thiamine or pyruvate and
did not improve ocular palsy, confabulation, ataxia or
peripheral neuropathy (Table 36). In contrast, the admin¬
istration of thiamine propyl disulphide either as the
initial agent or the second agent, with failure to respond
to other oral thiamine preparations, caused a rapid in¬
crease in blood and spinal fluid thiamine, reduction in
pyruvate and disappearance of ocular palsy (Figure 43, 44,
45). Following such therapy confabulation and other
mental abnormalities disappeared in 3, signs of ataxia and
peripheral neuropathy disappeared in 3.
Thiamine depletion represents the second most common
vitamin deficiency in chronic alcoholics (Leevy et al., 1969),
FIGURE 42. Cerebrospinal fluid thiamine concentra¬
tions in control and deficient subjects before and
six hours after 50 mgm. of thiamine hydrochloride
















































































































































































FIGURE 43. Blood thiamine and pyruvate levels in a
patient with Wernicke's encephalopathy given 50 mgm.
of thiamine hydrochloride (THC1) orally initially














FIGURE 44. Cerebrospinal fluid thiamine, lactate and
pyruvate levels in a patient with Wernicke's enceph¬
alopathy given 50 mgm. of thiamine pyrophosphate (TPP)
orally initially and 50 mgm. of thiamine propyl













FIGURE 45. Blood thiamine and pyruvate levels in a
patient with Wernicke's encephalopathy given 50 mgm.










randomly selected hospitalized patients (Leevy, et al.,
1965) and pregnant women (Thomson, et al., 1969). Only
folic acid which has not been widely used as a supplement
because of law or precedent is more commonly deficient.
In some instances, deficiency syndromes result from in¬
ability to convert thiamine into its metabolically active
form because of liver disease (Fennelly et al., 1967) or
nucleic acid abnormalities (Leevy, et al., 1969). Most
patients with thiamine depletion have not ingested ade¬
quate thiamine or fail to absorb sufficient amounts of
the vitamin to care for increased needs imposed by tissue
injury. Availability of a protozoologic method which
provides a reliable measure of the active form of thiamine
in biologic fluids and tissues makes it possible to study
the effectiveness of the various congeners of this vita¬
min# in clinical practice.
DISCUSSION
Matsokawa and Kawasaki introduced three alli-thia-
mines: thiamine allyl disulphide, thiamine methyl disul-
phide and thiamine propyl disulphide, each of which
produces significantly higher blood and urine levels than
thiamine hydrochloride or thiamine nitrate (Matsokawa and
Kawasaki, 1952). Thiamine propyl disulphide has been the
most satisfactory of the alli-thiamines (Shimazono and
Katsura, 1965) . It was found that oral thiamine propyl
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disulphide is absorbed more readily with a lower faecal
loss than occurs with thiamine hydrochloride. Moreover,
following its oral administration, a significantly higher
level was found in the blood and liver with ready entry
into other body fluids and tissues (Takenouchi and Aso,
1964).
35S--thiamine propyl disulphide experiments indicate
that following its intravenous administration thiamine
propyl disulphide splits into thiamine sulphide within
blood cells, the latter escapes into the plasma and is
bound to albumin (Fajiwara, et al., 1964). In vitro
studies suggest the same mechanism occurs in intestinal
transport and that thiamine propyl disulphide is converted
into thiamine and then cocarboxylase (Hioco, et al., 1959).
Thiamine propyl disulphide has the disadvantage of being
less water-soluble than thiamine hydrochloride (Matsukawa,
et al., 1962).
The present study demonstrates that orally administered
thiamine propyl disulphide produces a significantly higher
blood and urinary level of thiamine than thiamine hydro¬
chloride in malnourished alcoholics. Previous studies
using 35S-thiamine hydrochloride indicate that its intes¬
tinal absorption may be described by the Michaelis-Menten
kinetics (Michaelis and Menton, 1913). Blood levels and
urinary excretion of thiamine, after receipt of thiamine
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propyl disulphide .in the present study increased in a linear
fashion with larger oral doses without limitation to absorp¬
tion over the dose range tested.
The absorption of both forms of thiamine were markedly
diminished in malnourished alcoholic patients with fatty
liver; however, absorption of thiamine propyl disulphide
far exceeded that of thiamine hydrochloride as judged by
blood and urinary thiamine levels. Low levels of thiamine
often persisted under these circumstances in patients
receiving thiamine hydrochloride, however, thiamine propyl
disulphide absorption was consistently adequate to correct
the thiamine deficit. This was best demonstrated in sub¬
jects with Wernicke's encephalopathy in whom thiamine
hydrochloride or thiamine pyrophosphate failed to increase
either blood or spinal fluid thiamine while equimolar
quantities of thiamine propyl disulphide rapidly corrected
deficits. Repeated doses of thiamine hydrochloride could
prevent a deficiency state or eventually correct body
deficits, however, this varies considerably and cannot be
relied upon in the alcoholic (Figure 46).
Thiamine propyl disulphide has been used widely in
Japan; its administration over periods of months to years
has not been associated with any untoward effects. No ill
effects were encountered when we gave this drug to normal
volunteers or malnourished alcoholics with and without
FIGURE 46. Blood and urinary thiamine concentration
in a deficient patient given 20 mgm. of thiamine
hydrochloride (THCl) orally initially and 20 mgm.
of thiamine propyl disulphide (TPD) orally after
24 hours.
THIAMINECONCENTRATION(m/jgm/m!) THIAMINEEXCRETION(pgm/24Hr)
symptomatic thiamine deficiency for periods up to 3 months.
Oral thiamine propyl disulphide rapidly corrected bio¬
chemical ana clinical abnormalities due to thiamine de¬
pletion. It thus appears that this form of thiamine is
valuable for prevention and treatment of thiamine defici¬
ency states.
Pauling, 1968, has postulated that cerebral avitam-
inosis without overall body depletion may cause mental
disfunction. No evidence was found to support this hy¬
pothesis for thiamine and reduced amounts of this vitamin
in the CSF. appears to be a reflection of body depletion
of thiamine. Neurologic disease attendant to a deficiency
of thiamine is a common complication of alcoholism which
could be prevented in part by use of readily absorbable
forms of this vitamin. There are several alli-thiamine
homologues and S-acyl-thiamine derivatives which are more
readily absorbed from the intestine and penetrate red
cells and tissues with greater facility than thiamine
hydrochloride. Wide use of a more absorbable form of
thiamine in pretzels and other carbohydrates on which alco¬
holics and many impoverished people subsist could reduce
greatly the incidence and sequelae of thiamine depletion.
Consideration should, therefore, be given to substitution
of thiamine propyl disulphide or a similar preparation for




Evolution has made animals dependent upon environ¬
mental supplies of vitamins. Natural changes in the
surroundings or modifications imposed by man may limit
their supply. Disease processes or orally administered
agents may interfere with specialised mechanisms developed
for their absorption or prevent adequate utilization
imposing serious physical and mental limitations upon the
individual. Investigations were undertaken to examine the
critical role of intestinal absorption in determining the
thiamine status in man. It was thought that the behaviour
of thiamine may be representative of other rate limited
nutrients.
The measurement of absorption in man must often be
indirect and it is difficult to separate the processes
of utilization and storage from absorption. Additional
problems in assessing thiamine absorption have been due
to an inability to measure thiamine and its metabolites
accurately. Investigations using 35S-thiamine hydro¬
chloride indicate that radioactive thiamine can be used
to study the absorption of this vitamin in man. It is
evident that sufficient thiamine can be absorbed to meet
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daily requirements in the presence of adequate intake of
other nutrients and normal liver function. The absorption
of thiamine hydrochloride is limited. The existence of a
special mechanism for absorption of a substance so highly
diffusible suggests that it has developed to exclude
excessive amounts of thiamine rather than to ensure ade¬
quate absorption. Failure of this mechanism may occur
because of destruction of these sites as in primary mal-
absorptive disease (ideopathic steatorrhoci) , may result
from ethanol ingestion or malnutrition and liver disease.
Absorption is corrected when the pathological process
returns to normal or following the cessation of ethanol.
However, during the period when these patients have the
greatest need to replace their depleted stores and repair
damaged tissues, they are unable to absorb thiamine hydro¬
chloride adequately. The use of thiamine propyl disulphide
(TPD), which is absorbed by simple diffusion, allows us to
overcome the block imposed by the intestine and provides
an adequate supply of the metabolically active form of this
vitamin.
These investigations have been limited to the absorp¬
tion of only one of the vitamins. Information on the
influence of disease on the absorption of other vitamins
in man or of the inter-relationship of one vitamin upon
another, is extremely limited. The incidence of vitamin
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deficiency is only now being recognized and its full
effect on the development and efficiency of intellectual
and physical abilities is not known. If man is to succeed
in remodelling his environment, future research must
investigate and solve these problems.
Dr. A. D. Thomson
SUMMARY OF THESIS
A method has been developed to measure vitamin Bjl
absorption in man by measuring urinary and serum radio¬
activity following an oral dose of radioactive 35S-thia-
mine hydrochloride given along with a parenteral injection
of non-radioactive thiamine. Analysis of small intestinal
juice and characterization of radioactive material in the
urine indicated that little breakdown of thiamine occurred
in the intestine or during its passage through the body
under the conditions of the test. The amount absorbed,
urinary and serum patterns of radioactivity were established
in control subjects. Studies using combined umbilical and
hepatic vein catheterization indicated that thiamine, which
was absorbed high in the gastro-intestinal tract, initially
appeared in the portal blood and subsequently in the hepatic
venous and arterial blood. Mathematical formulations used
to describe enzyme-substrate interactions (Michaelis-Menton)
were found applicable to thiamine hydrochloride absorption.
Based on 72 hour urinary excretion, normal subjects had a
mean Vmax of 4.2 mgm. in comparison with a Vmax of 1.1 mgm.
in a patient with intestinal resection. Old age was not
associated with an inevitable reduction in absorption and
deficient circulating levels of thiamine could be avoided
if the diet provided the recommendable allowance.
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Patients with primary malabsorptive disease (ideopathic
steatorrhoea) exhibited a significant reduction in intes¬
tinal absorption of 35S-thiamine which returned to normal
following treatment with a gluten free diet. Investigations
in malnourished alcoholics demonstrated a marked decrease
in thiamine hydrochloride, absorption in the absence of
steatorrhoea, radiologic abnormalities or significant histol¬
ogical changes in the jejunum, attributed to a decrease in
the number of receptor sites available. The block of absorp¬
tion demonstrated to be at the intestinal level only re¬
turned to normal following receipt of a high protein-vitamin
supplemented diet for 6 to 8 weeks. Ethanol (1.5 gm/kgra.)
given either parenterally or orally, caused a 50% reduction
in thiamine absorption in 4 or 12 healthy subjects providing
an explanation for the occurrence of thiamine deficiency
syndromes despite ingestion of food containing minimum
requirements of this vitamin.
The absorption of thiamine propyl disulphide (TPD)
was investigated using a protozoologic technique (Ochro-
monas danica). The route of absorption was shown also to
be via the portal vein but the absorption was not found to be
rate limited. This permitted the intestinal block imposed
by malnutrition to be effectively bypassed. Cerebrospinal
(CSF) and blood thiamine levels were measured in normal sub¬
jects and in patients with symptomatic thiamine depletion.
Results indicated that reduced amounts of thiamine in CSF
was a reflection of body depletion of the vitamin. When
congeners of thiamine with different membrane transport
capacity ( -hydrochloride (THCl), -propyldisulphide (TPD),
and -pyrophosphate (TPP) ) were used for repletion studies
inadequate intestinal absorption of THCl and TPP failed to
correct thiamine deficiency or reverse the neurological
signs of Werneke's encephalopathy. Thiamine propyl disul-
phide (TPD) consistently produced high blood and CSF levels
after oral administration. It was shown to be metabol-
ically effective by relieving the symptoms of encepholopathy
and exhibited no untoward effects. Because of the unpre¬
dictability of thiamine hydrochloride (THCl) absorption in
the sick and injured it was recommended that thiamine
propyl disulphide (TPD) or another modification of thiamine
which is readily absorbed should replace the hydrochloride
moiety for food supplementation and oral therapy in the
malnourished alcoholic.
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SUMMARY
1. A method is described for investigating vitamin IE absorption in man by
measuring the urinary radioactivity during the 24 hr following an oral dose of radio¬
active [35S]thiamine which is given along with a parenteral injection of non-radio¬
active thiamine hydrochloride.
2. Analysis of small intestinal juice and characterization of radioactive material
in the urine indicate that the urine contains radioactive thiamine which was unchanged
prior to absorption.
3. In control subjects, the major period of thiamine absorption occurred within
the first 2 hr and practically all of the oral dose absorbed was excreted during the first
24 hr.
4. Eight patients with untreated primary malabsorptive disease (idiopathic
steatorrhoea) showed a mean urinary excretion of radioactive thiamine significantly
less than in the control group. The rate of excretion was markedly reduced but the
period of maximal excretion occurred at approximately the same time as in control
subjects. Thirteen patients with treated primary malabsorptive disease showed no
significant difference from the control group.
5. Ten patients who had undergone gastric surgery and two with resection of the
terminal ileum excreted amounts which did not differ from the control group. Normal
results were also found in four patients with pernicious anaemia.
Disease of the small intestine may cause impaired absorption of certain water-soluble vitamins.
Patients with primary malabsorptive disease (idiopathic steatorrhoea), for example, frequently
fail to absorb folic acid normally (Girdwood, 1953; Chanarin, Anderson & Mollin, 1958;
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Cox el al., 1958; Girdwood & Delamore, 1961). Although clinical evidence of deficiency of
other water-soluble vitamins is rarely present, investigations using the tryptophan loading test
have suggested subclinical deficiency of pyridoxine in patients with tropical sprue and primary
malabsorptive disease (Kowlessar et al., 1961; Sigler etal., 1962). Baker & Sobotka (1962) have
shown that patients with primary malabsorptive disease may have subnormal levels of serum
pyridoxine and Brain & Booth (1964), using tritium-labelled pyridoxine, have demonstrated
impaired absorption of pyridoxine in some of these patients.
Girdwood (1956), using microbiological methods, studied the absorption of water-soluble
vitamins in patients with primary malabsorptive disease, but found no evidence of malabsorp¬
tion of thiamine, riboflavin or pyridoxine in ten patients with impaired absorption of folic acid.
Except for this investigation, little has been published on the absorption of thiamine in patients
with intestinal malabsorption.
The availability of 35S-labelled thiamine has allowed some of the limitations of the micro¬
biological methods to be overcome. This paper presents a method for the measurement of
thiamine absorption using radioactive thiamine and compares the results found in control
subjects with those obtained in various groups of patients with gastro-intestinal disorders.
MATERIALS AND METHODS
Materials used
All of the thiamine preparations were supplied as the hydrochloride. 35S-labelled thiamine
was obtained from the Radiochemical Centre, Amersham. The radioactive material used
orally had a specific activity of 177 mCi/g and was found to be radiochemically pure when
tested in the three chromatographic systems described below. The solid material was dissolved
in distilled water, 100 /<Ci (ten doses) dispensed into each ampoule, freeze dried and stored at
— 20°. It was reconstituted by adding 10 ml distilled water. In a few experiments, radioactive
thiamine was used intravenously. This material was supplied in aqueous solution, pH 5; it had
a specific activity of 12-0 /<Ci/ml and analysis showed that it was more than 90% radiochemical^
pure. The non-radiocative thiamine was supplied in ampoules containing 100 mg in 1 ml by
Roche Products Ltd, England.
Method for the study of absorption of 35 S-Iabelled thiamine
The radioactive material was diluted with non-radioactive thiamine so that each test dose
contained TO mg and 10 qCi of radioactivity dissolved in 20 ml of water. A quantity of the
solution from which the test dose was prepared was used as a standard. The test dose was
given orally to subjects after an overnight fast, and in some experiments a parenteral injection
of non-radioactive thiamine was given immediately before the oral dose. The standard test
referred to later includes both a TO mg oral dose of radioactive thiamine and a parenteral
injection of 200 mg non-radioactive thiamine given at the same time as the oral dose. Absorp¬
tion was assessed by measuring the urinary radioactivity during the following 24 hr. The urine
collections were removed after the intervals 0-5, 5-12 and 12-24 hr, the volume measured and
a sample stored at —20° until the radioactivity was measured. The urine samples were counted
in an Isotope Developments Ltd, Reading, Berkshire, liquid scintillation counter type 6012,
using 0-8 g/100 ml of 2-5-diphenyloxazoIe and 0-005 g/100 ml of 1,4-bis(2[5-phenyloxazolyl])
benzene dissolved in toluene as the liquid scintillator. The samples were prepared by adding
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1-0 ml urine to 3 ml hyamine chloride, 1-5 m solution in methanol, and adding 10 ml liquid
scintillator. To each sample, 10 pd of the test dose was added as an internal standard.
Identity of the radioactivity present in intestinal contents and urine after oral administration of
35S-label/ecl thiamine. Urine was collected in a brown bottle surrounded by a freezing mixture
of ice and solid carbon dioxide (Drikold, I.C.I. Ltd), during the periods 0-1^, 1^-3 and 3-12 hr.
Following voiding, the urine was either analysed immediately or stored at —20°. A modifica¬
tion of the phenol extraction procedure of lacono & Johnson (1957) was used to extract the
radio-metabolites from the urine. Over 90% of the radioactivity was removed by this method.
Descending chromatography was performed on Whatman No. 1 paper using n-propanol-
water-m-acetate buffer, pH 5 (70 : 20 : 10), the upper phase of n-butanol-acetic acid-water
(40 : 10 : 50), and the upper phase of s-butanol-water as solvents. The papers were scanned
in a BTL Radioactive Chromatogram Scanner and radioautographs were prepared with
Gavert no-screen X-ray film; the film was exposed to the chromatogram for up to 3 months,
depending on the amount of radioactivity.
Identification of thiamine compounds on paper chromatograms
A. Thiochrome test. After drying the chromatograms at room temperature thiamine and its
esters present on the paper were converted to the corresponding thiochromes by the method
of Siliprandi & Siliprandi (1954); this test will detect 1-0 pg thiamine.
B. Use of micro-organisms. Some chromatograms were not sprayed but were scanned and
the radioactivity eluted with 3 ml distilled water. The ability of the eluate to support growth
of O. danica, which requires intact thiamine (Heinrich, 1955; Baker et al., 1964), was compared
with a control consisting of an equivalent area cut from the same chromatogram. The method
of Baker et al. (1964) was used for thiamine assay. Following incubation, the material was
centrifuged at 3000 rev/min for 30 min and subsequently washed by centrifuging after re-
suspension in two aliquots of 20 ml sterile distilled water. The radioactivity could not be washed
from the organisms. The organisms were finally suspended in gel-scintillator and the radio¬
activity present counted by well-scintillation counting.
C. Separation of radioactive compounds. To confirm that complete separation had been
achieved, two chromatograms were run in each of the three solvent systems and the radio¬
activity corresponding to thiamine eluted as above. Each of the eluates was then re-run in a
different chromatographic solvent system and produced a single spot at the same RF as thiamine.
The radioautographs also showed a single discrete spot.
Demonstration of thiamine and its metabolites in the urine. Four patients were given 300 mg
of non-radioactive thiamine hydrochloride intravenously 48 hr before the experiment. On the
day of the experiment they received the standard test of 1-0 mg oral radioactive thiamine
hydrochloride and 200 mg non-radioactive thiamine intravenously. In three subjects, over
90% of the radioactivity excreted during the 0-12 hr period had the same RF as thiamine in all
three solvent systems and gave a positive thiochrome test. The eluted radioactive substances
supported the growth of O. danica and the radioactivity could not be washed from the cells. In
the fourth subject, during the period lj-3 hr after the dose 90% of the radioactivity was due
to thiamine but this fell to 60% in the 3-12 hr period. No attempt was made to identify the
other radioactive compounds.
Extraction of radio-metabolites from small intestinal juice. Two normal subjects were intu¬
bated using a 1-5 mm bore polyvinyl tube weighted at one end. The duodenal-jejunal junction
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is approximately 90 cm and the ileo-caecal valve 350 cm from the nose in adults (Blankenhorn,
Hirsch & Ahrens, 1955). Sampling in one subject was from points 105 and 195 cm from the
nose on two successive days, i.e. from the jejunum and from the proximal ileum; in the other,
sampling was only from the proximal ileum. The fasting subjects were fed a test meal
consisting of'Humanized Trufood' (Trufood Ltd, The Creamaries, Wrenbury, Cheshire) and
5 /.id of [35S]thiamine with sufficient non-radioactive thiamine to give a final thiamine content
of 1 -0 mg. The small intestinal juice was obtained by continuous sampling into a flask surroun¬
ded by a freezing mixture. The volume of intestinal juice decreased considerably after the third
hour. Consequently, the observations relate to the 0-3 hr period. The pH of the intestinal
juice was measured with a glass electrode and never rose above pH 6T, i.e. it was always
within the range at which thiamine is stable. At the end of the experiment, gastrografin was
introduced into the tube to check the position of the sampling point.
Twenty ml of small intestinal juice were dialysed against three 100 ml portions of distilled
water left for 24 hr at 4°. The dialysates were freeze-dried and then dissolved in 30 ml absolute
ethanol. The solution was concentrated in vacuo at 35° to about 4 ml and a sample chromato-
graphed. It was found that over 90% of the radioactivity was identical, chromatographically,
with thiamine.
Subjects studied
Controls were sixty-five convalescent, ambulant hospital patients free from gastro-intestinal,
endocrine, collagen and malignant diseases. They had normal hepatic and renal function and
were not receiving drug therapy. They showed no signs of nutritional deficiency.
Patients with primary malabsorptive disease included ten cases who had not been treated
with a gluten-free diet. The diagnosis was established by jejunal biopsy and the results of the
following absorption tests—folic acid absorption (Girdwood, 1953; Girdwood & Delamore,
1961), vitamin B]2 absorption (Schilling, 1953), xylose absorption (Fourman, 1948) and faecal
fatexcretion(Kamere/tf/., 1949). A sternal marrow was performed and serum folate, formimino-
glutamic acid (FIGLU), and vitamin B12 levels were measured. All patients had a barium
meal and follow-through examinations. There were also thirteen patients who had been treated
with a gluten-free diet for periods varying from 3 months to 5 years.
The other patients included ten who had had gastric surgery and three patients with perni¬
cious anaemia who had confirmed acid-fast achlorhydria in response to a maximum histamine
test meal and were untreated at the time of investigation. Three patients had Crohn's disease
and one who had had a sub-total proximal gastrectomy with an end-to-side oesophago-gastric
anastamosis for an anaplastic carcinoma of the stomach 17 years previously, but there was no
post-mortem evidence of a recurrence when she died from a myocardial infarction some months
after completion of the studies. Two of the patients with Crohn's disease has had a resection
of the terminal iluem and a right hemicolectomy.
RESULTS
Investigation of test conditions.
The excretion of radioactivity when ten control subjects were only given 1-0 mg of radio¬
active thiamine orally was 6-1% (SEM + 0-64) but if the oral dose was preceded by giving
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300 mg of non-radioactive thiamine intravenously 48 hr before, the excretion of radioactive
thiamine rose to 15-3% (SEM + 2-63). This difference is highly significant (t = 4-26, P <0-01).
The standard test. The effect of varying the size of an intravenous dose of non-radioactive
thiamine given at the same time as the oral dose of radioactive material was studied and the
the optimum amount for this intravenous flushing dose was found to be 200 mg. This dose
ensured maximal excretion and was thereafter used in the standard test of thiamine absorption
(Table 1). Giving thiamine to control subjects 2 days before they received the standard test
did not alter the mean urinary excretion of radioactivity (Table 1) (t = 0-814, 0-2<P<0-5).
Fig. 1 shows the cumulative excretion of radioactivity after 200 mg flushing dose in a control
subject who received 300 mg thiamine intravenously 48 hr before. Excretion was maximal
Table 1. Twenty-four hour urinary excretion of radioactive thiamine by
normal subjects: The effect of injecting varying amounts of non-radio¬
active thiamine at the time of administering 1-0 mg radioactive thiamine
by mouth on the excretion of radioactive thiamine in the urine
Urinary excretion of radioactivity
Intravenous dose of non- ("/ oral dose*)
radioactive thiamine
(mg) Before loading After loading")
0 6-1+0-64 (10) 15-3 ±2-63 (6)
25 35-0 + 2-95 (5)
50 39-5 ±3-18 (7)
100 51-7 ±5-04 (9)
200 48-2±4-54 (10) 54-1 + 5-66 (10)
300 50-2 + 3-66 (8)
* The results are expressed as the mean ± SEM («). Urine was collected
for 24 hr.
t Subjects given 300 mg thiamine i.v. 48 hr before test, and a further
dose of thiamine at the time of the test.
between 1-2 hr during which time 41% of the dose was excreted. By 12 hr, excretion was
almost complete, 3% being added in 12-24 hr, and further small amounts thereafter (3-4%
in 24-38 hr and 4-1% in the 48-96 hr periods after which excreted radioactivity was too small
to be measured accurately).
The decline in the rate of excretion of urinary radioactivity 2 hr after the standard test may
not have been due to a decrease in the absorption of oral thiamine but may have followed a
fall in the blood level of the flushing dose due to the rapid excretion. Consequently, radioactive
thiamine (5-0 /rCi) was incorporated in a 200 mg intravenous injection on non-radioactive
thiamine to investigate the duration of the flushing dose. This showed that 4-5% (9-0 mg) of
the intravenous dose was still being excreted during the 4-5 hr period. Similarly, varying the
time of the flushing dose or maintaining a high blood level of non-radioactive thiamine during
the first 16 hr by repeated injections had a negligible effect on the total urinary recovery
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(Table 2). When the standard test alone was repeated in four subjects, the following results
were obtained: 46-0, 38-4; 49-0, 54-0; 58-4, 54-7; 60-0, 62-7%.
Eighty-eight per cent of the intravenous dose was recovered during the first 24 hr and 90%
after the radioactive thiamine was given intramuscularly to the same subject (Fig. 2). Another
subject excreted 93% of an intravenous dose in 24 hr. Consequently, it seems that practically
Fig. 1. Cumulative urinary excretion of radioactivity after 10 mg [35S]thiamine orally and 200 mg
non-radioactive thiamine intravenously in a control subject (•) and in a patient with primary mal-
absorptive disease (■).
all of the oral dose absorbed, once it reaches the blood stream, will probably be excreted
during the first 24 hr, under the conditions of the standard test.
Studies on patients
Primary malabsorptive disease. The excretion of eight patients with primary malabsorptive
disease given 300 mg intravenously 48 hr before the standard test was 26-7 (SEM + 5-11) which
was significantly less than the control group (/ = 3-504, EcO-Ol). When the 300 mg 'loading'
dose was omitted there was no decrease in the recovery of urinary radioactivity 28-1% (SEM
+4-75). The difference between these patients and the controls was not due to a decreased ability
to excrete thiamine as a patient was able to excrete an intravenous dose normally. The cumu¬
lative excretion of radioactivity in a 'loaded' untreated patient showed delay in excretion and
marked reduction in the total excreted 9-4% although maximal excretion occurred within the
first 6 hr (Fig. 1). Additional flushing doses given to three malabsorptive patients during the
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0-24 hr period and to two others during the 24—48 hr period did not alter the pattern of
excretion or significantly increase the total radioactivity excreted; the details of one patient
are shown in Table 3.
In thirteen patients who had been treated with a gluten-free diet and replacement therapy,
previous loading again had no effect on the excretion of radioactivity (Table 4). The previously
Table 2. Effect of varying the time of the initial flushing dose
and giving additional intravenous flushing doses













Subjects were given two tests: First* and Secondf and
received 300 mg non-radioactive thiamine intravenously
48 hr before each test.
* First test, TO mg radioactive thiamine orally and 200 mg
non-radioactive thiamine flushing dose intravenously at the
same time.
t Second test, Subjects 1-3 same as first test with addi¬
tional 100 mg flushing doses at 2, 6 and 12 hours after oral
dose; Subject 4, same as first test with additional 200 mg at
4 hr; Subject 5, received 200 mg i.m. only at time of oral
dose; Subject 6, no flushing dose at time of oral dose but
200 mg i.v. 1 hr after.
'loaded', treated patients did not differ from the control group (t = 2-012, 0-5</5<0-l) but
differed significantly from the untreated patients (t = 2-231, 0-02<P<0-05).
Miscellaneous conditions. The results of eight patients with gastroenterostomies are shown
in Fig. 3 and there is no evidence of abnormal absorption (t = 0-395, P<0-5).
One patient with a partial gastrectomy excreted 71-6% of the oral dose while another
excreted only 3-8%; this second patient had an abnormal villous pattern which may have been
associated with altered gastric function. He excreted 89% in the first 24 hr when the same dose
was given intravenously. A patient who had had a sub-tota gastrectomy 117 years previously
excreted 65-5%.
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Fig. 2. The radioactivity in serum (x) and urine (•) after administration of radioactive thiamine
(a) intramuscularly, and (b) intravenously, on different occasions to the same control subject.
200 mg non-radioactive thiamine were given intravenously along with the radioactive thiamine.
Table 3. Effect of additional flushing doses in a patient with untreated primary
malabsorptive disease
Time Urinary radioactivity
(hr) after standard test
Time of additional



























The patient was given 300 mg thiamine intravenously 48 hr before each test.
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Table 4. Thiamine absorption in patients with primary mal-
absorptive disease
Subjects No. of subjects Before loading After loading
Untreated 8 28-1 +4-75 26-7±5-ll
Treated 13 36-9 + 4-33 40-8 ±3-84
Standard test repeated in the same subject after giving 300 mg
thiamine intravenously 48 hr before the second test.
The results are expressed as the mean + SEM («).
Loading was achieved as before (see Table 1).
Primary Gastro- Crohn's Pernicious




54-1 26-7 40-8 56-9
5166 5-11 3-84 3-48
3, Thiamine absorption in various clinical states.
Mean
i SE
176 A. D. Thomson
Three patients with Crohn's disease involving the terminal ileum, who had evidence of
malabsorption of vitamin B12 and a reduced serum vitamin Bl2 level, gave normal results
(Fig. 3). Four patients with untreated pernicious anaemia also showed normal results.
DISCUSSION
These investigations indicate that radioactive thiamine can be used to study the absorption
of this vitamin in man. Analysis of small intestinal juice and extraction of the radioactivity
present in the urine shows that, during the period when maximal absorption is taking place,
little breakdown of thiamine occurs in the small intestine and that most of the radioactivity
obtained in the urine is thiamine which was unchanged prior to absorption.
When a relatively large injection of non-radioactive thiamine is given intravenously, the
percentage excretion of radioactivity rises from about 6-0% to over 50-0%. Since the non¬
radioactive parenteral thiamine promotes the urinary excretion of the labelled vitamin, it
would seem that the radioactive thiamine behaves similarly to the non-radioactive thiamine
during its passage through the body. Increasing the flushing dose to 300 mg thiamine does not
produce any further increase in the percentage urinary excretion of radioactive thiamine
(Table 1, T<0-5) and it would therefore seem unlikely that the flushing dose is altering the
normal physiological activity of the intestine.
If an absorption test is to be sensitive to physiological amounts of the test substance, the
size of the test dose must be large enough to show that the subject is capable of absorbing his
minimum daily requirement during the 24 hr but must not exceed the reserve capacity of the
intestine in the control subject. The minimum daily requirement of thiamine for the adult
human has been estimated at between 0-23 and 0-66 mg/1000 cal (Williams et al., 1942;
Oldham et al., 1944; Daum, Tuttle & Wilson, 1949; Dick et al., 1958; Ziporin et al., 1965).
The work of Morrison & Campbell (1960), Friedmann et al. (1948) and Schultz, Light &
Frey (1938) suggests that little further absorption occurs when the dose of thiamine exceeds
4-5 mg. Therefore 1-0 mg was chosen as a reasonable oral dose.
Although one control patient excreted 90-7% of the oral dose within the first 24 hr, the
mean excretion for the group was only 54-1% (SEM + 5-66) and prolonging the urine collection
for 9 days in one subject added only a further 7-5%. The total thiamine content of the human
body has been estimated to be 30 mg (Takeda, 1947). An attempt was made to reduce any
exchange with the body stores by previous loading of the patient and by the provision of
additional flushing doses each of 200 mg of non-radioactive thiamine to dilute the absorbed
radioactive thiamine. Flowever, giving additional flushing doses, or variation in time or route
of administration of the flushing dose, did not significantly increase the total 24 hr excretion
of activity nor alter the pattern of excretion. Also Yano (1958) recovered approximately 0-5 mg
of a 2-0 mg oral dose of thiamine from the stool. Consequently, it would seem that most of the
oral dose absorbed is excreted during the first 24 hr, under the conditions of the test. Haugen
(1961) showed that excessive amounts of thiamine are rapidly excreted by the kidney and in
the present investigation there was no evidence that at any time the kidneys were unable to
excrete the load presented to them.
In control subjects the major period of absorption was in the first 2 hr after the oral dose
(Fig. 1). The work of Middleton & Grice (1964) in the rat indicates that the site of maximum
absorption for thiamine is in the duodenum and upper small intestine, and this agrees with the
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findings of Polin et at. (1964) in the chick. Three patients with Crohn's disease involving the
lower small intestine and showing impaired absorption of vitamin B12 excreted normal amounts
of radioactivity after the standard test for thiamine, suggesting that absorption of vitamin B(
in the human is mainly in the upper small intestine.
Wang & Harris (1939) and Brummer & Markkanen (1960) measured the daily urinary
excretion of dietary thiamine in achlorhydric subjects and found evidence of reduced excretion
indicating depletion which might have been secondary to reduced absorption. During the
present investigation, four patients with pernicious anaemia and three with histamine-fast
achlorhydria following gastric surgery, were all found to excrete normal amounts of radio¬
activity. If absorption is grossly impaired, malabsorption may become apparent when the test
dose is small. A larger oral dose, however, may result in a greater difference between normals
and patients or may demonstrate impairment which was not obvious with the smaller dose as
occurs with xylose absorption. Consequently, the results in alchorhydria are not necessarily
incompatible with the observations of Wang & Harris (1939) and Brummer & Markkanen
(1960) although there may be other factors producing depletion in their patients.
The paired /-test showed no significant difference between malabsorptive patients who had
been previously loaded and those who had not, either before, or after, treatment. It was also
shown that the mean of the untreated malabsorptive patients with previous 'loading' was
significantly less than the treated patients. However, the mean of the treated malabsorptive
patients, who were not given 300 mg 48 hr before treatment, was low. Consequently, further
statistical tests were applied. Seven of the eight differences in the untreated patients were
positive but the result of the Wilcoxon's sign test (Spiegel, 1956) confirmed the /-test findings.
Similarly, in control subjects, previous 'loading' did not significantly alter the result. Conse¬
quently, the average of the result before and after 'loading' was taken in each malabsorptive
patient and the resulting two groups compared with the control group considered as twenty
independent observations. A one-way analysis of variance on these three groups was found
to be highly significant, confirming the difference between the untreated and control groups.
P[F± 5-21, d.f. (2,38)] = 0-99. The one-tailed /-test applied to the average of the treated and
untreated malabsorptive patients, gave / = 1-8 with 19 d.f. and this was significant at the 5%
level. There was no correlation between the ability of the malabsorptive patients to absorb
thiamine and other intestinal absorption tests or with the severity of the changes shown by
jejunal biopsy. The results in these patients illustrate again the variation in the ability of
individual patients to absorb different substances during the acute phase of the disease.
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Thiamine Absorption in Old Age
By A.D.Thomson
Introduction
Evidence of thiamine deficiency has recently been reported in
elderly subjects {Brin et al., 1964; Brin et al., 1965; Griffiths et al.,
1965). The role of intestinal absorption in determining the nutri¬
tional status, however, has not been extensively studied in old age.
This problem is of particular interest because of reports ofstructural
changes in the small intestine in later life (.Lascalea, 1959; Andrew,
1961; Suntzeff and Angeletti, 1961), and the demonstration by Fry
et al. (1961) of a reduced rate of cell production with aging in the
jejunal crypts of mice.
In old age too, there have been reports of impaired absorption
of fat (Becker et al., 1950), amino acids (Wild et al., 1953), galactose
[Meyer et al., 1943) and of certain vitamins - vitamin A (Yiengst and
Shock, 1949) and vitamin B12 [Chow, 1954; Glass et al., 1955). How¬
ever, Chinnetal. (1956) found no significant difference in the rate or
the extent of protein digestion and absorption in old age and the
findings of impaired absorption of vitamin B12 have not been con¬
firmed by subsequent work (Swenseid et al., 1954; Chow et al., 1956;
Tauber et al., 1957; Hyams, 1964).
Rajsky and Newman (1943) measuring the urinary excretion of
thiamine in twenty-two elderly subjects found that a larger dose
was required to produce a constant output than in younger subjects
and concluded that absorption was poorer in the older individual.
The work of Draper (1958) in the rat showed that the absorption of
an oral dose of radiothiamine decreased substantially beyond the
age of 20 months. Kirk and Chiefi (1951) measuring faecal thiamine
in man, however, found little change in percentage absorption with
increasing age at the dose level used.
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It is possible to study vitamin Bx absorption in man using sul¬
phur-labelled thiamine (Thomson, 1966) and in the present study its
absorption is compared in 24 elderly patients and 21 younger
subjects.
Method and Patients
Vitamin B1 absorption was measured using sulphur-labelled thiamine hydrochloride
as described by Thomson (1966) modified by giving two additional oral doses. 35S-
thiamine, specific activity 158.2 mc/g was shown to be radiochemically pure when
tested in the following chromatographic systems; N-propanol/water/IM acetate buffer
pH 5 (70:20:10) : N-butanol/acetic acid/water (40:10:50), sec-butanol/water and iso-
propanol/hydrochloric acid/water (130:33:37). The radioactive material was diluted
with non-radioactive thiamine so that each test dose contained 1.0 mg, 5.0 mg or 20.0
mg of thiamine and 5 //c of radioactivity dissolved in 20 ml of water. The test dose was
given orally after an overnight fast and a parenteral injection of 200 mg of non-radio¬
active thiamine hydrochloride was given immediately before the oral dose. Urine
collections were removed after 5 h, 12 h, 24 h and 48 h and counted in a Packard Tri-
carb liquid scintillation counter.
Adequacy of the flushing dose when used with larger oral doses of radioactive thiamine
was tested. Twenty-four control subjects were given either 1.0 mg, 5.0 mg or 20.0 mg of
radioactive thiamine orally together with 200 mg of non-radioactive thiamine intra-
venously. The results were compared with those obtained in the same subject, given the
same test as before, but with additional 100 mg intravenous injections of non-radioactive
thiamine at 4 h, 9 h, 12 h and 24 h after the oral dose. Urine was collected for 72 h after
each test (Table I). A one-way analysis of variance computed on the difference between
the two tests showed that giving extra flushing doses did not significantly alter the
excretion. P [F da 0.704; d.f. (2,22)] = 0.99. Similar results were found when the two
tests were given to three subjects over the age of 80 years using 20.0 mg oral dose;
23.5%, 24.2%; 21.0%, 22.7%; 17.7%, 16.3%. The giving of additional flushing doses
did not significantly increase the total excretion of activity nor alter the pattern of
excretion.
Table I
Effect of additional intravenous flushing doses in controls




Urinary excretion of radioactivity
% oral dose*
First test** Second test***
1.0 44.7 ± 5.75 (8) 45.4 ± 5.65 (8)
5.0 33.0 ± 2.68 (8) 35.3 ± 2.15 (8)
20.0 25.9 ± 2.62 (8) 25.5 ± 1.68 (8)
* The results are expressed as the mean ± S.E. (n).
** First test. 1.0 mg, 5.0 mg, or 20.0 mg of radioactive thiamine orally and 200 mg
of non-radioactive thiamine flushing dose intravenously at the same
time.
*** Second test. Same as for first test with additional 100 mg flushing doses at 4, 9,
12 and 24 h after oral dose.
Urine was collected for 72 h.
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Subjects. Two groups of convalescent hospital in-patients who were free from haema-
tological, gastro-intestinal, endocrine or malignant disease, were studied:
Group I consisted of 24 subjects aged 76-90 years (mean 82.1 years). Group II
consisted of 21 younger subjects aged from 28-56 years (mean 48.9 years). Fifteen
members of the older group were given a test at each of the three oral dose levels, i. e.
1.0 mg, 5.0 mg and 20.0 mg of thiamine. The order in which the tests were performed
was randomised. The remaining nine were given one test only. Ethical reasons prevented
more than two tests being carried out on any individual in the younger group. The dose
to be omitted was again determined from random number tables (Documenta Geigy,
1965).
Results
The results obtained are summarised in Table II. In Fig. 1-3
the percentage excretion of radioactivity of both the younger and
the older groups, at each dose level, have been plotted against age.
Table II
Thiamine absorption in younger and older groups




Urinary excretion of radioactivity
% oral dose*
Older Younger
1.0 53.1 ± 3.03 (21) 51.8 ± 2.97 (16)
5.0 33.4 ± 2.14 (17) 40.8 ± 4.71 (12)
20.0 21.2 ± 1.23 (18) 25.8 ± 3.69 (14)
* The results are expressed as the mean ± S.E. (n). Urine was collected for 48 h.
Subjects were given 200 mg of non-radioactive thiamine flushing dose intra¬
venously at the time of the oral dose.
A regression analysis was performed at each of the dose levels but
no correlation between age and the percentage excretion of radio¬
activity could be demonstrated. [At 1.0 mg, oral dose/age t =
± 0.002 (35 d.f.) p > 0.5; 5.0 mg t = ± 0.687 (27 d.f.) p =
0.5; 20.0 mg t = ± 0.673 (30 d.f.) p > 0.5].
Discussion
The results agree with those of Kirk and Chieffi. (1951). They
measured faecal thiamine using a chemical method (Hennessy and
Cerecedo, 1939; Friedmann and Kmieciak, 1943) before, during and
after a 5.0 mg daily oral supplement but found little change in the
percentage absorption with increasing age. The minimum daily
requirement of thiamine for the young adult has been estimated at
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Fig. 2. Excretion of 5.0 mg oral dose 35S-thiamine at different ages.
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Fig. 3. Excretion of 20.0 mg oral dose 35S-thiamine at different ages.
# Younger group.
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between 0.23 mg/1000 cal and 0.66 mg/1000 cal (Williams et a/..,
1942; Oldham et al., 1944; Daum et al., 1949; Dick et al., 1958;
Ziporin et al., 1965) and the daily allowance suggested by the
National Research Council is 1.3 mg per day (National Research
Council Publication, 1958). Evidence suggests that for the rat {Mills,
1948) and for man (Oldham, 1962) this requirement may be in¬
creased in old age. However, both at a physiological level and at
very much larger doses, no difference in absorption has been found
between the two groups in this present study. This is not to say that
deficiency may not occur due to inadequate intake of thiamine.
Poor diets may result from prejudice about food or follow mental
deterioration, or heat labile nutrients may be destroyed by pro¬
longed cooking. Striking deterioration in health and nutrition has
been reported in the late seventies when both weight loss and re¬
duction in calorie intake often occur (Exton-Smith and Stanton, 1965).
Because of the criteria of selection, no comments can be made
on the absorption of patients with haematological, gastro-intestinal,
endocrine or malignant disease. Nor were any subjects studied who
had advanced protein malnutrition in which severe intestinal
atrophy has been observed {Passmore, 1947-1948; Gillman and
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Gillman, 1951; Brock, 1961; Deo and Ramalingaswami, 1964). How¬
ever, the findings do suggest that there is not an inevitable decline
with age in the ability of the intestine to absorb vitamin Bi and
that deficiency in most elderly people need not arise provided that
adequate amounts are present in the diet.
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Summary
The ability of 24 elderly subjects (mean age 82.1 years) to
absorb thiamine has been investigated using three oral doses 1.0 mg,
5.0 mg and 20.0 mg. The results were compared with those in 21
younger subjects (mean age 48.9 years) but no evidence of impaired
absorption was found. No inevitable decline with age in the ability
of the intestine to absorb vitamin Bj seems to occur and deficiency
in most elderly people probably need not arise provided they are
receiving an adequate diet.
/jusammenfassung
Bei 24 alten Personen (82,1 Jahre durchschnittlich) wurde die Thiaminresorption
bei Einnahme von 1,0 mg, 5,0 mg und 20,0 mg oral untersucht. Die Resultate wurden
mit den von 21 jiingern Personen verglichen (38,9 Jahre durchschnittlich), aber es
konnte kein Unterschied in der Absorption festgestellt werden. Es scheint, daG im Alter
keine unvermeidliche Abnahme der Vitamin Bj-Resorption im Darm vorkommt; der
Mangel bei den meisten alten Leuten milBte bei entsprechender Diat nicht vorkommen.
Resume
Les auteurs ont teste le pouvoir d'absorption de la Vitamine Bx chez 24 sujets ag^s
(age moyen de 82,1 ans). Les resultats furent compares k ceux enregistres chez 21 sujets
plus jeunes (age moyen 48,9 ans). Aucune alteration evidente de la capacite d'absorp¬
tion n'a pu etre objectivee. Les carences chez le vieillard semblent done pouvoir 6tre
facilement evitees k condition que celui-ci beneficie d'un regime equilibre.
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